Digestive Diseases Publications
Clara Abraham, MD
- Interleukin-23 p19 and Interleukin-12 p40, Head-to-Head, against Gut Inflammation.Abraham C. N Engl J Med. 2024 Jul 18. PMID: 39018537.
- Modulating microbiome-immune axis in the deployment-related chronic diseases of Veterans: report of an expert meeting.Sun J, Ince MN, Abraham C, Barrett T, Brenner LA, Cong Y, Dashti R, Dudeja PK, Elliott D, Griffith TS, Heeger PS, Hoisington A, Irani K, Kim TK, Kapur N, Leventhal J, Mohamadzadeh M, Mutlu E, Newberry R, Peled JU, Rubinstein I, Sengsayadeth S, Tan CS, Tan XD, Tkaczyk E, Wertheim J, Zhang ZJ. Gut Microbes. 2023 Dec; 2023 Oct 16. PMID: 37842912.
- ScRNA-seq defines dynamic T-cell subsets in longitudinal colon and peripheral blood samples in immune checkpoint inhibitor-induced colitis.Mann JE, Lucca L, Austin MR, Merkin RD, Robert ME, Al Bawardy B, Raddassi K, Aizenbud L, Joshi NS, Hafler DA, Abraham C, Herold KC, Kluger HM. J Immunother Cancer. 2023 Aug. PMID: 37586769.
- IL-12 and IL-23 pathway inhibition in inflammatory bowel disease.Verstockt B, Salas A, Sands BE, Abraham C, Leibovitzh H, Neurath MF, Vande Casteele N. Nat Rev Gastroenterol Hepatol. 2023 Jul; 2023 Apr 17. PMID: 37069321.
- Pattern Recognition Receptor Signaling and Cytokine Networks in Microbial Defenses and Regulation of Intestinal Barriers: Implications for Inflammatory Bowel Disease.Abraham C, Abreu MT, Turner JR. Gastroenterology. 2022 May; 2022 Feb 9. PMID: 35149024.
- The Tight Junction Protein ZO-1 Is Dispensable for Barrier Function but Critical for Effective Mucosal Repair.Kuo WT, Zuo L, Odenwald MA, Madha S, Singh G, Gurniak CB, Abraham C, Turner JR. Gastroenterology. 2021 Dec; 2021 Aug 31. PMID: 34478742.
- Ubiquitination of ATF6 by disease-associated RNF186 promotes the innate receptor-induced unfolded protein response.Ranjan K, Hedl M, Sinha S, Zhang X, Abraham C. J Clin Invest. 2021 Sep 1. PMID: 34623328.
- The E3 ubiquitin ligase RNF186 and RNF186 risk variants regulate innate receptor-induced outcomes.Ranjan K, Hedl M, Abraham C. Proc Natl Acad Sci U S A. 2021 Aug 10. PMID: 34353900.
- TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk Variants.Sun R, Hedl M, Abraham C. Cell Mol Gastroenterol Hepatol. 2021; 2020 Aug 19. PMID: 32827707.
- Myeloid Cell Expression of LACC1 Is Required for Bacterial Clearance and Control of Intestinal Inflammation.Kang JW, Yan J, Ranjan K, Zhang X, Turner JR, Abraham C. Gastroenterology. 2020 Sep; 2020 Jul 18. PMID: 32693188.
- Disease Risk-Associated Genetic Variants in STAT1 and STAT4 Function in a Complementary Manner to Increase Pattern-Recognition Receptor-Induced Outcomes in Human Macrophages.Hedl M, Sun R, Abraham C. J Immunol. 2020 Sep 1; 2020 Jul 13. PMID: 32661180.
- Myeloid Cell-Intrinsic IRF5 Promotes T Cell Responses through Multiple Distinct Checkpoints In Vivo, and IRF5 Immune-Mediated Disease Risk Variants Modulate These Myeloid Cell Functions.Yan J, Hedl M, Abraham C. J Immunol. 2020 Aug 15; 2020 Jul 20. PMID: 32690658.
- T Cell-Intrinsic IRF5 Regulates T Cell Signaling, Migration, and Differentiation and Promotes Intestinal Inflammation.Yan J, Pandey SP, Barnes BJ, Turner JR, Abraham C. Cell Rep. 2020 Jun 30. PMID: 32610123.
- IL23 induces IL23R recycling and amplifies innate receptor-induced signalling and cytokines in human macrophages, and the IBD-protective IL23R R381Q variant modulates these outcomes.Sun R, Hedl M, Abraham C. Gut. 2020 Feb; 2019 May 16. PMID: 31097538.
- IL23 Promotes Antimicrobial Pathways in Human Macrophages, Which Are Reduced With the IBD-Protective IL23R R381Q Variant.Sun R, Abraham C. Cell Mol Gastroenterol Hepatol. 2020; 2020 May 29. PMID: 32474165.
- LACC1 Required for NOD2-Induced, ER Stress-Mediated Innate Immune Outcomes in Human Macrophages and LACC1 Risk Variants Modulate These Outcomes.Huang C, Hedl M, Ranjan K, Abraham C. Cell Rep. 2019 Dec 24. PMID: 31875558.
- STAT3 and STAT5 Signaling Thresholds Determine Distinct Regulation for Innate Receptor-Induced Inflammatory Cytokines, and STAT3/STAT5 Disease Variants Modulate These Outcomes.Hedl M, Sun R, Huang C, Abraham C. J Immunol. 2019 Dec 15; 2019 Nov 15. PMID: 31732533.
- Prioritizing Crohn's disease genes by integrating association signals with gene expression implicates monocyte subsets.Gettler K, Giri M, Kenigsberg E, Martin J, Chuang LS, Hsu NY, Denson LA, Hyams JS, Griffiths A, Noe JD, Crandall WV, Mack DR, Kellermayer R, Abraham C, Hoffman G, Kugathasan S, Cho JH. Genes Immun. 2019 Sep; 2019 Jan 29. PMID: 30692607.
- Correction to: Reducing IRF5 expression attenuates colitis in mice, but impairs the clearance of intestinal pathogens.Pandey SP, Yan J, Turner JR, Abraham C. Mucosal Immunol. 2019 Jul. PMID: 31182816.
- Reducing IRF5 expression attenuates colitis in mice, but impairs the clearance of intestinal pathogens.Pandey SP, Yan J, Turner JR, Abraham C. Mucosal Immunol. 2019 Jul; 2019 May 3. PMID: 31053739.
- Twist1 and Twist2 Induce Human Macrophage Memory upon Chronic Innate Receptor Treatment by HDAC-Mediated Deacetylation of Cytokine Promoters.Sun R, Hedl M, Abraham C. J Immunol. 2019 Jun 1; 2019 Apr 26. PMID: 31028123.
- Challenges in IBD Research: Precision Medicine.Denson LA, Curran M, McGovern DPB, Koltun WA, Duerr RH, Kim SC, Sartor RB, Sylvester FA, Abraham C, de Zoeten EF, Siegel CA, Burns RM, Dobes AM, Shtraizent N, Honig G, Heller CA, Hurtado-Lorenzo A, Cho JH. Inflamm Bowel Dis. 2019 May 16. PMID: 31095701.
- IRF5 Is Required for Bacterial Clearance in Human M1-Polarized Macrophages, and IRF5 Immune-Mediated Disease Risk Variants Modulate This Outcome.Hedl M, Yan J, Witt H, Abraham C. J Immunol. 2019 Feb 1; 2018 Dec 28. PMID: 30593537.
- INAVA-ARNO complexes bridge mucosal barrier function with inflammatory signaling.Luong P, Hedl M, Yan J, Zuo T, Fu TM, Jiang X, Thiagarajah JR, Hansen SH, Lesser CF, Wu H, Abraham C, Lencer WI. Elife. 2018 Oct 25; 2018 Oct 25. PMID: 30355448.
- Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells.Zhu S, Ding S, Wang P, Wei Z, Pan W, Palm NW, Yang Y, Yu H, Li HB, Wang G, Lei X, de Zoete MR, Zhao J, Zheng Y, Chen H, Zhao Y, Jurado KA, Feng N, Shan L, Kluger Y, Lu J, Abraham C, Fikrig E, Greenberg HB, Flavell RA. Nature. 2017 Jun 29; 2017 Jun 21. PMID: 28636595.
- E3 Ubiquitin ligase ZNRF4 negatively regulates NOD2 signalling and induces tolerance to MDP.Bist P, Cheong WS, Ng A, Dikshit N, Kim BH, Pulloor NK, Khameneh HJ, Hedl M, Shenoy AR, Balamuralidhar V, Malik NBA, Hong M, Neutzner A, Chin KC, Kobayashi KS, Bertoletti A, Mortellaro A, Abraham C, MacMicking JD, Xavier RJ, Sukumaran B. Nat Commun. 2017 Jun 28; 2017 Jun 28. PMID: 28656966.
- Human LACC1 increases innate receptor-induced responses and a LACC1 disease-risk variant modulates these outcomes.Lahiri A, Hedl M, Yan J, Abraham C. Nat Commun. 2017 Jun 8; 2017 Jun 8. PMID: 28593945.
- ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation.Schumacher MA, Hedl M, Abraham C, Bernard JK, Lozano PR, Hsieh JJ, Almohazey D, Bucar EB, Punit S, Dempsey PJ, Frey MR. Cell Death Dis. 2017 Feb 23; 2017 Feb 23. PMID: 28230865.
- Lessons Learned From Trials Targeting Cytokine Pathways in Patients With Inflammatory Bowel Diseases.Abraham C, Dulai PS, Vermeire S, Sandborn WJ. Gastroenterology. 2017 Feb; 2016 Oct 22. PMID: 27780712.
- JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold Determines Innate Receptor-Induced Proinflammatory Cytokine Secretion in Macrophages.Hedl M, Proctor DD, Abraham C. J Immunol. 2016 Nov 1; 2016 Sep 23. PMID: 27664279.
- A TPL2 (MAP3K8) disease-risk polymorphism increases TPL2 expression thereby leading to increased pattern recognition receptor-initiated caspase-1 and caspase-8 activation, signalling and cytokine secretion.Hedl M, Abraham C. Gut. 2016 Nov; 2015 Jul 27. PMID: 26215868.
- A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.Chuang LS, Villaverde N, Hui KY, Mortha A, Rahman A, Levine AP, Haritunians T, Evelyn Ng SM, Zhang W, Hsu NY, Facey JA, Luong T, Fernandez-Hernandez H, Li D, Rivas M, Schiff ER, Gusev A, Schumm LP, Bowen BM, Sharma Y, Ning K, Remark R, Gnjatic S, Legnani P, George J, Sands BE, Stempak JM, Datta LW, Lipka S, Katz S, Cheifetz AS, Barzilai N, Pontikos N, Abraham C, Dubinsky MJ, Targan S, Taylor K, Rotter JI, Scherl EJ, Desnick RJ, Abreu MT, Zhao H, Atzmon G, Pe'er I, Kugathasan S, Hakonarson H, McCauley JL, Lencz T, Darvasi A, Plagnol V, Silverberg MS, Muise AM, Brant SR, Daly MJ, Segal AW, Duerr RH, Merad M, McGovern DP, Peter I, Cho JH. Gastroenterology. 2016 Oct; 2016 Jul 1. PMID: 27377463.
- IRF5 and IRF5 Disease-Risk Variants Increase Glycolysis and Human M1 Macrophage Polarization by Regulating Proximal Signaling and Akt2 Activation.Hedl M, Yan J, Abraham C. Cell Rep. 2016 Aug 30; 2016 Aug 18. PMID: 27545875.
- MTMR3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activation.Lahiri A, Hedl M, Abraham C. Proc Natl Acad Sci U S A. 2015 Aug 18; 2015 Aug 3. PMID: 26240347.
- Twist1 and Twist2 Contribute to Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages through the Coordinated Regulation of Transcriptional Repressors and Activators.Zheng S, Hedl M, Abraham C. J Immunol. 2015 Jul 1; 2015 May 27. PMID: 26019273.
- T cell-extrinsic CD18 attenuates antigen-dependent CD4+ T cell activation in vivo.Wu X, Lahiri A, Sarin R, Abraham C. J Immunol. 2015 May 1; 2015 Mar 23. PMID: 25801431.
- TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophages.Zheng S, Hedl M, Abraham C. J Immunol. 2015 Feb 15; 2015 Jan 7. PMID: 25567680.
- Activation of pattern recognition receptors up-regulates metallothioneins, thereby increasing intracellular accumulation of zinc, autophagy, and bacterial clearance by macrophages.Lahiri A, Abraham C. Gastroenterology. 2014 Oct; 2014 Jun 21. PMID: 24960189.
- A TNFSF15 disease-risk polymorphism increases pattern-recognition receptor-induced signaling through caspase-8-induced IL-1.Hedl M, Abraham C. Proc Natl Acad Sci U S A. 2014 Sep 16; 2014 Sep 2. PMID: 25197060.
- The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways.Hedl M, Zheng S, Abraham C. J Immunol. 2014 Jun 15; 2014 May 19. PMID: 24842757.
- Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn's disease ICOSLG risk allele.Hedl M, Lahiri A, Ning K, Cho JH, Abraham C. Immunity. 2014 May 15. PMID: 24837102.
- NOD2 regulates CXCR3-dependent CD8+ T cell accumulation in intestinal tissues with acute injury.Wu X, Lahiri A, Haines GK 3rd, Flavell RA, Abraham C. J Immunol. 2014 Apr 1; 2014 Mar 3. PMID: 24591373.
- NF-κB1 inhibits NOD2-induced cytokine secretion through ATF3-dependent mechanisms.Zheng S, Abraham C. Mol Cell Biol. 2013 Dec; 2013 Oct 7. PMID: 24100018.
- The influence of depression on quality of life in patients with inflammatory bowel disease.Zhang CK, Hewett J, Hemming J, Grant T, Zhao H, Abraham C, Oikonomou I, Kanakia M, Cho JH, Proctor DD. Inflamm Bowel Dis. 2013 Jul. PMID: 23669400.
- NLRP1 and NLRP3 inflammasomes are essential for distinct outcomes of decreased cytokines but enhanced bacterial killing upon chronic Nod2 stimulation.Hedl M, Abraham C. Am J Physiol Gastrointest Liver Physiol. 2013 Mar 15; 2013 Jan 3. PMID: 23287275.
- Age and CD161 expression contribute to inter-individual variation in interleukin-23 response in CD8+ memory human T cells.Shen H, Zhang W, Abraham C, Cho JH. PLoS One. 2013; 2013 Mar 1. PMID: 23469228.
- Nod2-induced autocrine interleukin-1 alters signaling by ERK and p38 to differentially regulate secretion of inflammatory cytokines.Hedl M, Abraham C. Gastroenterology. 2012 Dec; 2012 Sep 8. PMID: 22967725.
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine.Huber S, Gagliani N, Zenewicz LA, Huber FJ, Bosurgi L, Hu B, Hedl M, Zhang W, O'Connor W Jr, Murphy AJ, Valenzuela DM, Yancopoulos GD, Booth CJ, Cho JH, Ouyang W, Abraham C, Flavell RA. Nature. 2012 Nov 8; 2012 Oct 17. PMID: 23075849.
- CD18 is required for optimal lymphopenia-induced proliferation of mouse T cells.Sarin R, Abraham C. Am J Physiol Gastrointest Liver Physiol. 2012 Oct; 2012 Jul 19. PMID: 22821945.
- IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells.Hedl M, Abraham C. J Immunol. 2012 Jun 1; 2012 Apr 27. PMID: 22544929.
- Effector CD4+ T cell expression signatures and immune-mediated disease associated genes.Zhang W, Ferguson J, Ng SM, Hui K, Goh G, Lin A, Esplugues E, Flavell RA, Abraham C, Zhao H, Cho JH. PLoS One. 2012; 2012 Jun 8. PMID: 22715389.
- The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans.Menard L, Saadoun D, Isnardi I, Ng YS, Meyers G, Massad C, Price C, Abraham C, Motaghedi R, Buckner JH, Gregersen PK, Meffre E. J Clin Invest. 2011 Sep; 2011 Aug 1. PMID: 21804190.
- Distinct roles for Nod2 protein and autocrine interleukin-1beta in muramyl dipeptide-induced mitogen-activated protein kinase activation and cytokine secretion in human macrophages.Hedl M, Abraham C. J Biol Chem. 2011 Jul 29; 2011 Jun 9. PMID: 21659536.
- Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses.Sarin R, Wu X, Abraham C. Proc Natl Acad Sci U S A. 2011 Jun 7; 2011 May 23. PMID: 21606346.
- Interactions between the host innate immune system and microbes in inflammatory bowel disease.Abraham C, Medzhitov R. Gastroenterology. 2011 May. PMID: 21530739.
- Secretory mediators regulate Nod2-induced tolerance in human macrophages.Hedl M, Abraham C. Gastroenterology. 2011 Jan; 2010 Sep 18. PMID: 20854823.
- Development of a nanoparticulate formulation of retinoic acid that suppresses Th17 cells and upregulates regulatory T cells.Capurso NA, Look M, Jeanbart L, Nowyhed H, Abraham C, Craft J, Fahmy TM. Self Nonself. 2010 Oct. PMID: 21487509.
- Unraveling the genetics of autoimmunity.Zenewicz LA, Abraham C, Flavell RA, Cho JH. Cell. 2010 Mar 19. PMID: 20303870.
- Inflammatory bowel disease.Abraham C, Cho JH. N Engl J Med. 2009 Nov 19. PMID: 19923578.
- Interleukin-23/Th17 pathways and inflammatory bowel disease.Abraham C, Cho J. Inflamm Bowel Dis. 2009 Jul. PMID: 19253307.
- IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease.Abraham C, Cho JH. Annu Rev Med. 2009. PMID: 18976050.
- A case of indometacin-induced acute hepatitis developing into chronic autoimmune hepatitis.Abraham C, Hart J, Locke SM, Baker AL. Nat Clin Pract Gastroenterol Hepatol. 2008 Mar; 2008 Jan 29. PMID: 18227818.
- Inflammatory bowel disease genetics: Nod2.Cho JH, Abraham C. Annu Rev Med. 2007. PMID: 16987083.
Harry Aslanian, MD
- Fine-Needle Aspiration Biopsy of Adrenal Gland Lesions: The Roles of Image Guidance, Rapid On-Site Evaluation and Additional Tissue Sampling.Yu S, Dolezal D, Aslanian HR, Cai G. Cytopathology. 2025 Jan 29; 2025 Jan 29. PMID: 39878416.
- Coexistent Eosinophilic Esophagitis and Dysplastic Barrett's Esophagus With Rapid Eosinophilic Infiltration of Neosquamous Mucosa After Radiofrequency Ablation.Ameyaw PA, Parsons D, Mahmoud A, Marie R, Nagar A, Aslanian HR. ACG Case Rep J. 2024 Sep; 2024 Aug 29. PMID: 39221230.
- Penile Prosthetic Pump Reservoir Mimicking a Cecal Subepithelial Mass.Ameyaw PA, Aslanian HR. ACG Case Rep J. 2024 Jul; 2024 Jul 12. PMID: 39006051.
- EUS-guided Gastroenterostomy: A Multicenter International Study Comparing Benign and Malignant Diseases.Kahaleh M, Tyberg A, Sameera S, Sarkar A, Shahid HM, Abdelqader A, Gjeorgjievski M, Gaidhane M, Muniraj T, Jamidar PA, Aslanian HR, Abraham M, Lajin M, Kedia P, Nieto J, Parsa N, Andalib I, Bashir M, Kowalski TE, Loren DE, Kumar A, Schlachterman A, Chiang A, Holmes I, Mendoza Ladd AH, Oleas R, Zolotarevsky E, Robles-Medranda C, Barthet M. J Clin Gastroenterol. 2024 Jul 1; 2024 Jul 1. PMID: 37646532.
- Clinical predictive value of renalase in post-ERCP pancreatitis.Muniraj T, Desir G, Gorelick FS, Guo X, Ciarleglio MM, Deng Y, Jamidar PA, Farrell J, Aslanian HR, Laine L. Gastrointest Endosc. 2024 May; 2023 Dec 14. PMID: 38103747.
- Endoscopic Ultrasound in Cancer Staging.Aslanian HR, Muniraj T, Nagar A, Parsons D. Gastrointest Endosc Clin N Am. 2024 Jan; 2023 Sep 27. PMID: 37973230.
- Endoscopic Removal of Ingested Wire Bristle from the Pancreas.Lerner BA, Aslanian HR, Muniraj T. Clin Gastroenterol Hepatol. 2022 Apr; 2021 Feb 17. PMID: 33609785.
- Evaluation of socioeconomic and healthcare disparities on same admission cholecystectomy after endoscopic retrograde cholangiopancreatography among patients with acute gallstone pancreatitis.Chouairi F, McCarty TR, Hathorn KE, Sharma P, Aslanian HR, Jamidar PA, Thompson CC, Muniraj T. Surg Endosc. 2022 Jan; 2021 Jan 22. PMID: 33481109.
- Gallbladder Cryoablation: Other Endoscopic Options for High-Risk Patients with Cholecystitis.Jones J, Aslanian HR, Muniraj T. Am J Med. 2021 Nov. PMID: 34799010.
- Factors associated with complete clip closure after endoscopic mucosal resection of large colorectal polyps.Ortiz O, Rex DK, Grimm IS, Moyer MT, Hasan MK, Pleskow D, Elmunzer BJ, Khashab MA, Sanaei O, Al-Kawas FH, Gordon SR, Mathew A, Levenick JM, Aslanian HR, Antaki F, von Renteln D, Crockett SD, Rastogi A, Gill JA, Law R, Wallace MB, Elias PA, MacKenzie TA, Pohl H, Pellisé M. Endoscopy. 2021 Nov; 2021 Apr 20. PMID: 33291159.
- Education and gastroenterology fellow knowledge about endoscopic mucosal resection of colon adenomas: a survey-based study.Garg S, Inamdar S, Tharian B, Muniraj T, Aslanian HR. Endosc Int Open. 2021 Aug; 2021 Jul 16. PMID: 34447869.
- Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies.Muniraj T, Aslanian HR, Laine L, Jamidar PA, Farrell JF, Mitchell KA, Salem RR. World J Gastroenterol. 2021 Apr 21. PMID: 33958848.
- Enhanced EUS imaging (with videos).Krishnan K, Bhutani MS, Aslanian HR, Melson J, Navaneethan U, Pannala R, Parsi MA, Schulman AR, Sethi A, Sullivan S, Trikudanathan G, Trindade AJ, Watson RR, Maple JT, Lichtenstein DR. Gastrointest Endosc. 2021 Feb; 2020 Oct 28. PMID: 33129492.
- Endoscopic ultrasound-guided fine needle aspiration cytology diagnosis of upper gastrointestinal tract mesenchymal tumors: Impact of rapid onsite evaluation and correlation with histopathologic follow-up.Gilani SM, Muniraj T, Aslanian HR, Cai G. Diagn Cytopathol. 2021 Feb; 2020 Oct 2. PMID: 33006819.
- Musculoskeletal Pain Symptoms and Injuries Among Endoscopists Who Perform ERCP.Campbell EV 3rd, Muniraj T, Aslanian HR, Laine L, Jamidar P. Dig Dis Sci. 2021 Jan; 2020 Mar 6. PMID: 32144599.
- Endoscopic management of gastric outlet obstruction of remnant stomach in a patient with Roux-en-Y gastric bypass.Kesar V, Magulick J, Kesar V, Muniraj T, Aslanian HR. VideoGIE. 2020 Nov; 2020 Aug 20. PMID: 33204916.
- Intestinal metaplasia around the gastroesophageal junction is frequently associated with antral reactive gastropathy: implications for carcinoma at the gastroesophageal junction.Vyas M, Celli R, Singh M, Patel N, Aslanian HR, Boffa D, Deng Y, Ciarleglio MM, Laine L, Jain D. Hum Pathol. 2020 Nov; 2020 Sep 14. PMID: 32941964.
- The Reply.Lam R, Jamidar PA, Aslanian HR, Muniraj T. Am J Med. 2020 Oct. PMID: 33004185.
- Esophageal stent-assisted biliary access.Campbell EV 3rd, Magulick J, Aslanian HR, Jamidar P. Gastrointest Endosc. 2020 Oct; 2020 May 1. PMID: 32360903.
- Fitz-Hugh-Curtis Syndrome Presenting as Acute Abdomen.Lam R, Jamidar PA, Aslanian HR, Muniraj T. Am J Med. 2020 Oct; 2020 Apr 9. PMID: 32277885.
- Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis.McCarty TR, Bazarbashi AN, Njei B, Ryou M, Aslanian HR, Muniraj T. Clin Endosc. 2020 Sep; 2020 Sep 29. PMID: 33027584.
- The New Virtual Reality: Advanced Endoscopy Education in the COVID-19 Era.Siddiqui UD, Aslanian HR. Dig Dis Sci. 2020 Jul. PMID: 32504351.
- AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.Aslanian HR, Lee JH, Canto MI. Gastroenterology. 2020 Jul; 2020 May 19. PMID: 32416142.
- Endoscopic ultrasound-guided fine needle aspiration of accessory spleen: Cytomorphologic features and diagnostic considerations.Gilani SM, Muniraj T, Farrell JJ, Aslanian HR, Cai G. Diagn Cytopathol. 2020 Jul; 2020 Apr 21. PMID: 32315514.
- Effects of Blended (Yellow) vs Forced Coagulation (Blue) Currents on Adverse Events, Complete Resection, or Polyp Recurrence After Polypectomy in a Large Randomized Trial.Pohl H, Grimm IS, Moyer MT, Hasan MK, Pleskow D, Elmunzer BJ, Khashab MA, Sanaei O, Al-Kawas FH, Gordon SR, Mathew A, Levenick JM, Aslanian HR, Antaki F, von Renteln D, Crockett SD, Rastogi A, Gill JA, Law RJ, Elias PA, Pellise M, Mackenzie TA, Rex DK. Gastroenterology. 2020 Jul; 2020 Mar 12. PMID: 32173478.
- Endoscopic rectal variceal ligation.Campbell EV 3rd, Aslanian HR, Muniraj T. VideoGIE. 2020 Jun; 2020 Jun 3. PMID: 32529163.
- Endoscopic ultrasound (EUS) and the management of pancreatic cancer.Yousaf MN, Chaudhary FS, Ehsan A, Suarez AL, Muniraj T, Jamidar P, Aslanian HR, Farrell JJ. BMJ Open Gastroenterol. 2020 May. PMID: 32414753.
- Fine needle aspiration cytology of peripancreatic myelolipoma.Huang Q, Parmer C, Muniraj T, Aslanian HR, Cai G. Diagn Cytopathol. 2020 May; 2020 Mar 9. PMID: 32150351.
- Endoscopic Resection of a Giant Duodenal Lipoma.Gnanapandithan K, Aslanian HR, Jamidar PA, Muniraj T. ACG Case Rep J. 2020 Mar; 2020 Mar 17. PMID: 32337302.
- Comparative effectiveness of pharmacologic and endoscopic interventions for prevention of post-ERCP pancreatitis: a network meta-analysis.Njei B, McCarty TR, Muniraj T, Sharma P, Jamidar PA, Aslanian HR, Varadarajulu S, Navaneethan U. Endosc Int Open. 2020 Jan; 2020 Jan 8. PMID: 31921982.
- Combined versus single use 20 G fine-needle biopsy and 25 G fine-needle aspiration for endoscopic ultrasound-guided tissue sampling of solid gastrointestinal lesions.van Riet PA, Giorgio Arcidiacono P, Petrone M, Quoc Nguyen N, Kitano M, Chang K, Larghi A, Iglesias-Garcia J, Giovannini M, van der Merwe S, Santo E, Baldaque-Silva F, Bucobo JC, Bruno MJ, Aslanian HR, Cahen DL, Farrell J. Endoscopy. 2020 Jan; 2019 Jul 22. PMID: 31330556.
- Clip Closure Prevents Bleeding After Endoscopic Resection of Large Colon Polyps in a Randomized Trial.Pohl H, Grimm IS, Moyer MT, Hasan MK, Pleskow D, Elmunzer BJ, Khashab MA, Sanaei O, Al-Kawas FH, Gordon SR, Mathew A, Levenick JM, Aslanian HR, Antaki F, von Renteln D, Crockett SD, Rastogi A, Gill JA, Law RJ, Elias PA, Pellise M, Wallace MB, Mackenzie TA, Rex DK. Gastroenterology. 2019 Oct; 2019 Mar 15. PMID: 30885778.
- Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing.Majumder S, Taylor WR, Yab TC, Berger CK, Dukek BA, Cao X, Foote PH, Wu CW, Mahoney DW, Aslanian HR, Fernández-Del Castillo C, Doyle LA, Farrell JJ, Fisher WE, Lee LS, Lee YN, Park W, Rodrigues C, Gould Rothberg BE, Salem RR, Simeone DM, Urs S, Van Buren G, Smyrk TC, Allawi HT, Lidgard GP, Raimondo M, Chari ST, Kendrick ML, Kisiel JB, Topazian MD, Ahlquist DA. Am J Gastroenterol. 2019 Sep. PMID: 31306149.
- Advances in the diagnosis and surveillance of Barrett's esophagus (with videos).Trindade AJ, Navaneethan U, Aslanian HR, Bhutani MS, Krishnan K, Lichtenstein DR, Melson J, Pannala R, Parsi MA, Schulman AR, Sethi A, Trikudanathan G, Watson RR, Maple JT. Gastrointest Endosc. 2019 Sep; 2019 May 18. PMID: 31113535.
- ASGE guideline for endoscopic full-thickness resection and submucosal tunnel endoscopic resection.Aslanian HR, Sethi A, Bhutani MS, Goodman AJ, Krishnan K, Lichtenstein DR, Melson J, Navaneethan U, Pannala R, Parsi MA, Schulman AR, Sullivan SA, Thosani N, Trikudanathan G, Trindade AJ, Watson RR, Maple JT. VideoGIE. 2019 Aug; 2019 Jun 29. PMID: 31388606.
- Devices for endoscopic hemostasis of nonvariceal GI bleeding (with videos).Parsi MA, Schulman AR, Aslanian HR, Bhutani MS, Krishnan K, Lichtenstein DR, Melson J, Navaneethan U, Pannala R, Sethi A, Trikudanathan G, Trindade AJ, Watson RR, Maple JT. VideoGIE. 2019 Jul; 2019 Jun 27. PMID: 31334417.
- Endoscopic simulators.Goodman AJ, Melson J, Aslanian HR, Bhutani MS, Krishnan K, Lichtenstein DR, Navaneethan U, Pannala R, Parsi MA, Schulman AR, Sethi A, Sullivan SA, Thosani N, Trikudanathan G, Trindade AJ, Watson RR, Maple JT. Gastrointest Endosc. 2019 Jul; 2019 May 20. PMID: 31122746.
- Perforation of the duodenum 2 weeks after lumen-apposing metal stent placement for malignant pyloric stricture.Muniraj T, Salem R, Olave-Martinez M, Suarez A, Aslanian HR. Gastrointest Endosc. 2019 May; 2019 Jan 10. PMID: 30639540.
- Endoscopic Ultrasound for the Diagnosis and Staging of Liver Tumors.Lange A, Muniraj T, Aslanian HR. Gastrointest Endosc Clin N Am. 2019 Apr. PMID: 30846157.
- Barrett's esophagus: A comprehensive review for the internist.Klavan H, Russell MB, Macklin J, Lee E, Aslanian HR, Muniraj T. Dis Mon. 2018 Nov; 2018 Jun 5. PMID: 29880269.
- Long-Term Follow-Up of Low-Risk Branch Duct IPMNs of the Pancreas: Watch for Main Pancreatic Duct Dilatation, and for How Long?Muniraj T, Aslanian HR. Clin Transl Gastroenterol. 2018 Oct 24; 2018 Oct 24. PMID: 30353003.
- Safety and rate of delayed adverse events with lumen-apposing metal stents (LAMS) for pancreatic fluid collections: a multicenter study.Yang D, Perbtani YB, Mramba LK, Kerdsirichairat T, Prabhu A, Manvar A, Ho S, Pannu D, Keswani RN, Strand DS, Wang AY, Quintero E, Buscaglia JM, Muniraj T, Aslanian HR, Draganov PV, Siddiqui AS. Endosc Int Open. 2018 Oct; 2018 Oct 8. PMID: 30302385.
- Cannabis Use Is Associated With Increased Risk of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Analysis of the US Nationwide Inpatient Sample Database, 2004-2014.Njei B, Sharma P, McCarty TR, Singh M, Haque L, Aslanian HR, Jamidar P, Muniraj T. Pancreas. 2018 Oct. PMID: 30134357.
- Endoscopic management of pancreatic duct disruption with large mediastinal pseudocyst.Ortiz V, Yousaf MN, Muniraj T, Jamidar P, Aslanian HR. VideoGIE. 2018 May; 2018 Mar 16. PMID: 29917026.
- EUS diagnosis of cystic pancreatic neuroendocrine tumors.Li-Geng T, Cai G, Aslanian HR. VideoGIE. 2018 Mar; 2018 Feb 28. PMID: 29916484.
- Endoscopic submucosal dissection for resection of submucosal tumors of the colon and rectum: Within reach, or the edge of tomorrow?Sahakian AB, Aslanian HR. Gastrointest Endosc. 2018 Feb. PMID: 29406933.
- EUS evaluation of liver lesions.Yousaf MN, Cai G, Aslanian HR. VideoGIE. 2018 Jan; 2017 Nov 11. PMID: 29905169.
- Endoscopic diagnosis of paraesophageal hernia with gastric volvulus.Yousaf MN, Duffy AJ, Aslanian HR. VideoGIE. 2017 Nov; 2017 Oct 12. PMID: 30027133.
- New Developments in Endoscopic Ultrasound Tissue Acquisition.Muniraj T, Aslanian HR. Gastrointest Endosc Clin N Am. 2017 Oct. PMID: 28918800.
- Primary Care Physicians Could Play a Role in Improving Colonoscopy Quality Measures.Langberg KM, Solad Y, Ciarleglio M, Sukumar N, Teslya P, Chowdhury MM, Aslanian HR. Dig Dis Sci. 2017 May; 2017 Mar 27. PMID: 28349232.
- Clinical utility of rapid on-site cytopathology.Oza VM, Cai G, Aslanian HR. Gastrointest Endosc. 2017 Jan; 2016 Aug 22. PMID: 27562939.
- Endoscopic Management of Pancreatic Fluid Collections.Muniraj T, Jamidar PA, Nealon WH, Aslanian HR. J Clin Gastroenterol. 2017 Jan. PMID: 27548730.
- Endoscopic Management of Esophagopleural Fistula.McCarty TR, Bakhit M, Aslanian HR, Rustagi T. J Clin Gastroenterol. 2016 Nov/Dec. PMID: 27552330.
- EUS Needle Identification Comparison and Evaluation study (with videos).Tang SJ, Vilmann AS, Saftoiu A, Wang W, Streba CT, Fink PP, Griswold M, Wu R, Dietrich CF, Jenssen C, Hocke M, Kantowski M, Pohl J, Fockens P, Annema JT, van der Heijden EH, Havre RF, Pham KD, Kunda R, Deprez PH, Mariana J, Vazquez-Sequeiros E, Larghi A, Buscarini E, Fusaroli P, Lahav M, Puri R, Garg PK, Sharma M, Maluf-Filho F, Sahai A, Brugge WR, Lee LS, Aslanian HR, Wang AY, Shami VM, Markowitz A, Siddiqui AA, Mishra G, Scheiman JM, Isenberg G, Siddiqui UD, Shah RJ, Buxbaum J, Watson RR, Willingham FF, Bhutani MS, Levy MJ, Harris C, Wallace MB, Nolsøe CP, Lorentzen T, Bang N, Sørensen SM, Gilja OH, D'Onofrio M, Piscaglia F, Gritzmann N, Radzina M, Sparchez ZA, Sidhu PS, Freeman S, McCowan TC, de Araujo CR Jr, Patel A, Ali MA, Campbell G, Chen E, Vilmann P. Gastrointest Endosc. 2016 Sep; 2016 Feb 10. PMID: 26873530.
- Confocal laser endomicroscopy features of sessile serrated adenomas/polyps.Parikh ND, Gibson J, Nagar A, Ahmed AA, Aslanian HR. United European Gastroenterol J. 2016 Aug; 2015 Dec 15. PMID: 27536371.
- Awash in a Multitude of Pancreas Cysts: Can We Stop Looking?Muniraj T, Aslanian HR. Clin Gastroenterol Hepatol. 2016 Jun; 2016 Feb 4. PMID: 26851707.
- Digital chromoendoscopy utilization in clinical practice: A survey of gastroenterologists in Connecticut.Langberg KM, Parikh ND, Deng Y, Ciarlegio M, Laine L, Aslanian HR. World J Gastrointest Pharmacol Ther. 2016 May 6. PMID: 27158543.
- Can a Computerized Simulator Assess Skill Level and Improvement in Performance of ERCP?Sahakian AB, Laine L, Jamidar PA, Siddiqui UD, Duffy A, Ciarleglio MM, Deng Y, Nagar A, Aslanian HR. Dig Dis Sci. 2016 Mar; 2015 Nov 14. PMID: 26572779.
- Endoscopic ultrasound-guided fine-needle aspiration diagnosis of secondary tumors involving the pancreas: An institution's experience.Alomari AK, Ustun B, Aslanian HR, Ge X, Chhieng D, Cai G. Cytojournal. 2016; 2016 Jan 28. PMID: 26955395.
- Endoscopic Treatment of Gastrointestinal Perforations, Leaks, and Fistulae.Rustagi T, McCarty TR, Aslanian HR. J Clin Gastroenterol. 2015 Nov-Dec. PMID: 26325190.
- Treatment of Refractory Gastrointestinal Strictures With Mitomycin C: A Systematic Review.Rustagi T, Aslanian HR, Laine L. J Clin Gastroenterol. 2015 Nov-Dec. PMID: 25626632.
- Endoscopic ultrasound-guided fine-needle aspiration biopsy of autoimmune pancreatitis: diagnostic clues and pitfalls.Cai G, Bernstein J, Aslanian HR, Hui P, Chhieng D. J Am Soc Cytopathol. 2015 Jul-Aug; 2015 Jan 21. PMID: 31051756.
- Is Advanced Endoscopy Training Worth it?Aslanian HR, Ahmed AM, Jamidar PA. Clin Gastroenterol Hepatol. 2015 Jul. PMID: 26091939.
- Variation in Aptitude of Trainees in Endoscopic Ultrasonography, Based on Cumulative Sum Analysis.Wani S, Hall M, Keswani RN, Aslanian HR, Casey B, Burbridge R, Chak A, Chen AM, Cote G, Edmundowicz SA, Faulx AL, Hollander TG, Lee LS, Mullady D, Murad F, Muthusamy VR, Pfau PR, Scheiman JM, Tokar J, Wagh MS, Watson R, Early D. Clin Gastroenterol Hepatol. 2015 Jul; 2014 Nov 14. PMID: 25460557.
- A double-blind, randomized, sham-controlled trial of the effect of a radiation-attenuating drape on radiation exposure to endoscopy staff during ERCP.Muniraj T, Aslanian HR, Laine L, Farrell J, Ciarleglio MM, Deng Y, Ho H, Jamidar PA. Am J Gastroenterol. 2015 May; 2015 Mar 31. PMID: 25823765.
- Endoscopic strangulation techniques for treatment of upper GI mucosal and submucosal lesions.Rustagi T, Aslanian HR. Gastrointest Endosc. 2015 Apr; 2014 Jul 12. PMID: 25028275.
- Influence of colonoscopy quality measures on patients' colonoscopist selection.Solad Y, Wang C, Laine L, Deng Y, Schwartz H, Ciarleglio MM, Aslanian HR. Am J Gastroenterol. 2015 Feb; 2014 Jul 29. PMID: 25070055.
- Cold snare polypectomy for large sessile colonic polyps: a single-center experience.Muniraj T, Sahakian A, Ciarleglio MM, Deng Y, Aslanian HR. Gastroenterol Res Pract. 2015; 2015 Mar 23. PMID: 25878658.
- Endoscopic management of biliary leaks after laparoscopic cholecystectomy.Rustagi T, Aslanian HR. J Clin Gastroenterol. 2014 Sep. PMID: 24296422.
- Endoscopic ultrasound-guided fine-needle aspiration diagnosis of Merkel cell carcinoma metastatic to the pancreas.Bernstein J, Adeniran AJ, Cai G, Theoharis CG, Ustun B, Beckman D, Aslanian HR, Harigopal M. Diagn Cytopathol. 2014 Mar; 2012 Jun 25. PMID: 22730170.
- The utility of esophagogastroduodenoscopy before endoscopic ultrasonography in patients undergoing endoscopic ultrasonography for pancreatico-biliary and mediastinal indications.Sahakian AB, Aslanian HR, Mehra M, Rossi F, Laine L, Sanchez M, Ciarleglio MM, Adimoolam V, Siddiqui UD. J Clin Gastroenterol. 2013 Nov-Dec. PMID: 23632349.
- Emphysematous Cholecystitis Resulting in Secondary Biliary Cirrhosis: A Rare Complication of Endoscopic Retrograde Cholangiopancreatography.Bari K, Aslanian HR, Pollak J, Reiner E, Salem RR, Taddei TH, Emre SH, Jamidar PA. ACG Case Rep J. 2013 Oct; 2013 Oct 8. PMID: 26157820.
- Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours: a multicentre case series.Ho HC, Eloubeidi MA, Siddiqui UD, Brugge WR, Rossi F, Bounds BW, Aslanian HR. Dig Liver Dis. 2013 Sep; 2013 Apr 9. PMID: 23582348.
- Performance of endoscopic ultrasound-guided fine needle aspiration in diagnosing pancreatic neuroendocrine tumors.Bernstein J, Ustun B, Alomari A, Bao F, Aslanian HR, Siddiqui U, Chhieng D, Cai G. Cytojournal. 2013; 2013 May 29. PMID: 23858320.
- Nurse observation during colonoscopy increases polyp detection: a randomized prospective study.Aslanian HR, Shieh FK, Chan FW, Ciarleglio MM, Deng Y, Rogart JN, Jamidar PA, Siddiqui UD. Am J Gastroenterol. 2013 Feb. PMID: 23381064.
- Pancreatic neuroendocrine tumors.Muniraj T, Vignesh S, Shetty S, Thiruvengadam S, Aslanian HR. Dis Mon. 2013 Jan. PMID: 23312533.
- Hypertriglyceridemia independent propofol-induced pancreatitis.Muniraj T, Aslanian HR. JOP. 2012 Jul 10; 2012 Jul 10. PMID: 22797405.
- Endoscopic ultrasound identifies synchronous pancreas cystic lesions not seen on initial cross-sectional imaging.Adimoolam V, Sanchez MJ, Siddiqui UD, Yu S, Dzuira JD, Padda MS, Aslanian HR. Pancreas. 2011 Oct. PMID: 21705942.
- Endoscopic ultrasound and endoscopic retrograde cholangiopancreatography for obstructing pancreas head masses: combined or separate procedures?Aslanian HR, Estrada JD, Rossi F, Dziura J, Jamidar PA, Siddiqui UD. J Clin Gastroenterol. 2011 Sep. PMID: 21301359.
- Patient preferences after endoscopic ultrasound with fine needle aspiration (EUS-FNA) diagnosis of pancreas cancer: rapid communication valued over long-term relationships.Siddiqui UD, Rossi F, Padda MS, Rosenthal LS, Aslanian HR. Pancreas. 2011 Jul. PMID: 21602735.
- Littoral cell angioma of the spleen diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy.Nagarajan P, Cai G, Padda MS, Selbst M, Kowalski D, Proctor DD, Chhieng D, Aslanian HR, Harigopal M. Diagn Cytopathol. 2011 May. PMID: 21488173.
- Endoscopic ultrasound and gastric lesions.Nagler AK, Aslanian HR, Siddiqui UD. J Clin Gastroenterol. 2011 Mar. PMID: 21278579.
- Narrow band imaging to detect residual or recurrent neoplastic tissue during surveillance endoscopy.Rogart JN, Aslanian HR, Siddiqui UD. Dig Dis Sci. 2011 Feb; 2010 Jun 9. PMID: 20532981.
- Gastric perforations associated with the use of crack cocaine.Chander B, Aslanian HR. Gastroenterol Hepatol (N Y). 2010 Nov. PMID: 21437024.
- EUS-guided FNA of solid pancreatic masses: a prospective, randomized trial comparing 22-gauge and 25-gauge needles.Siddiqui UD, Rossi F, Rosenthal LS, Padda MS, Murali-Dharan V, Aslanian HR. Gastrointest Endosc. 2009 Dec; 2009 Jul 28. PMID: 19640524.
- Young female with pancreatic mass.Padda MS, Aslanian HR, Theoharis C. Gastroenterology. 2009 Sep; 2009 Jul 29. PMID: 19646403.
- Massive hemobilia after transjugular liver biopsy treated endoscopically and angiographically.Rogart JN, Aslanian HR. Clin Gastroenterol Hepatol. 2008 Dec. PMID: 19081523.
- Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.Aslanian HR, Burgart LJ, Harrington JJ, Mahoney DW, Zinsmeister AR, Thibodeau SN, Ahlquist DA. Clin Gastroenterol Hepatol. 2008 Dec; 2008 Jul 17. PMID: 18639494.
- Screening colonoscopy and fecal occult blood testing practice patterns: a population-based survey of gastroenterologists.Rossi F, Sosa JA, Aslanian HR. J Clin Gastroenterol. 2008 Nov-Dec. PMID: 18936643.
- Fellow involvement may increase adenoma detection rates during colonoscopy.Rogart JN, Siddiqui UD, Jamidar PA, Aslanian HR. Am J Gastroenterol. 2008 Nov; 2008 Aug 27. PMID: 18759826.
David Assis, MD
- Quo vadis autoimmune hepatitis? - Summary of the 5(th) international autoimmune hepatitis group research workshop 2024.Engel B, Assis DN, Bhat M, Clusmann J, Drenth JP, Gerussi A, Londoño MC, Oo YH, Schregel I, Sebode M, Taubert R. JHEP Rep. 2025 Feb; 2024 Nov 12. PMID: 39897612.
- PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progress.Hayes CM, Gallucci GM, Boyer JL, Assis DN, Ghonem NS. Hepatol Commun. 2025 Jan 1; 2024 Dec 20. PMID: 39699308.
- Pathophysiology of Cystic Fibrosis Liver Disease.Kasper VL, Assis DN. Pediatr Pulmonol. 2024 Sep. PMID: 39105342.
- PPAR-Mediated Bile Acid Glucuronidation: Therapeutic Targets for the Treatment of Cholestatic Liver Diseases.Gallucci GM, Hayes CM, Boyer JL, Barbier O, Assis DN, Ghonem NS. Cells. 2024 Aug 1; 2024 Aug 1. PMID: 39120326.
- Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.Sellers ZM, Assis DN, Paranjape SM, Sathe M, Bodewes F, Bowen M, Cipolli M, Debray D, Green N, Hughan KS, Hunt WR, Leey J, Ling SC, Morelli G, Peckham D, Pettit RS, Philbrick A, Stoll J, Vavrina K, Allen S, Goodwin T, Hempstead SE, Narkewicz MR. Hepatology. 2024 May 1; 2023 Oct 26. PMID: 37934656.
- Autoimmune hepatitis: Brighton Collaboration case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.Kochhar S, Assis DN, Mack C, Izurieta HS, Muratori L, Munoz A, Nordenberg D, Gidudu JF, Blau EF, Vierling JM. Vaccine. 2024 Mar 7; 2024 Feb 16. PMID: 38368225.
- Advancing Second-Line Treatment for Primary Biliary Cholangitis.Assis DN. N Engl J Med. 2024 Feb 29; 2024 Feb 21. PMID: 38381658.
- African American race does not confer an increased risk of clinical events in patients with primary sclerosing cholangitis.Yazdanfar M, Zepeda J, Dean R, Wu J, Levy C, Goldberg D, Lammert C, Prenner S, Reddy KR, Pratt D, Forman L, Assis DN, Lytvyak E, Montano-Loza AJ, Gordon SC, Carey EJ, Ahn J, Schlansky B, Korzenik J, Karagozian R, Hameed B, Chandna S, Yu L, Bowlus CL. Hepatol Commun. 2024 Feb 1; 2024 Jan 29. PMID: 38285883.
- Advancing diagnosis and management of liver disease in adults through exome sequencing.Zheng M, Hakim A, Konkwo C, Deaton AM, Ward LD, Silveira MG, Assis DN, Liapakis A, Jaffe A, Jiang ZG, Curry MP, Lai M, Cho MH, Dykas D, Bale A, Mistry PK, Vilarinho S. EBioMedicine. 2023 Sep; 2023 Aug 9. PMID: 37566928.
- Recent Advances in the Management of Primary Sclerosing Cholangitis.Assis DN, Bowlus CL. Clin Gastroenterol Hepatol. 2023 Jul; 2023 Apr 19. PMID: 37084929.
- Research gaps and opportunities in autoimmune hepatitis-Results of the international autoimmune hepatitis group research workshop 2022.Snijders RJALM, Assis DN, Oo YH, Sebode M, Taubert R, Willemse J, Tomsin B, Lohse AW, Drenth JPH, Gevers TJG. Liver Int. 2023 Jul; 2023 Apr 10. PMID: 37035872.
- Reply: Insurance should cover vancomycin for primary sclerosing cholangitis.Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Hepatology. 2023 Jun 1; 2023 Jan 26. PMID: 36695291.
- Reply: Living donor liver transplantation for people with PSC.Forman LM, Sapisochin G, Assis DN, Arrivé L, Bergquist A, Bowlus CL, Deneau M, Ilyas SI, Lunsford KE, Martinez M, Shroff R, Tabibian JH. Hepatology. 2023 May 1; 2023 Jan 3. PMID: 36732294.
- Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease.Sayed A, Assis DN, Silveira MG, Deng Y, Ciarleglio M, Gaidos JKJ, Proctor DD, Al-Bawardy B. Eur J Gastroenterol Hepatol. 2023 Mar 1; 2023 Jan 17. PMID: 36708297.
- Unique DUOX2(+)ACE2(+) small cholangiocytes are pathogenic targets for primary biliary cholangitis.Li X, Li Y, Xiao J, Wang H, Guo Y, Mao X, Shi P, Hou Y, Zhang X, Zhao N, Zheng M, He Y, Ding J, Tan Y, Liao M, Li L, Peng Y, Li X, Pan Q, Xie Q, Li Q, Li J, Li Y, Chen Z, Huang Y, Assis DN, Cai SY, Boyer JL, Huang X, Tang CE, Liu X, Peng S, Chai J. Nat Commun. 2023 Feb 9; 2023 Feb 9. PMID: 36759512.
- AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma.Bowlus CL, Arrivé L, Bergquist A, Deneau M, Forman L, Ilyas SI, Lunsford KE, Martinez M, Sapisochin G, Shroff R, Tabibian JH, Assis DN. Hepatology. 2023 Feb 1; 2022 Oct 20. PMID: 36083140.
- Update in Advancing the Gastrointestinal Frontier in Cystic Fibrosis.Vélez C, Freedman SD, Assis DN. Clin Chest Med. 2022 Dec. PMID: 36344078.
- Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary Cholangitis.Gallucci GM, Alsuwayt B, Auclair AM, Boyer JL, Assis DN, Ghonem NS. Inflammation. 2022 Dec; 2022 Jul 15. PMID: 35838934.
- Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitis.Alrabadi LS, Dutton A, Rabiee A, Roberts SJ, Deng Y, Cusack L, Silveira MG, Ciarleglio M, Bucala R, Sinha R, Boyer JL, Assis DN. JHEP Rep. 2022 May; 2022 Feb 18. PMID: 35434588.
- Adjunct Fenofibrate Up-regulates Bile Acid Glucuronidation and Improves Treatment Response For Patients With Cholestasis.Gallucci GM, Trottier J, Hemme C, Assis DN, Boyer JL, Barbier O, Ghonem NS. Hepatol Commun. 2021 Dec; 2021 Aug 27. PMID: 34558841.
- Defining Primary Sclerosing Cholangitis: Results From an International Primary Sclerosing Cholangitis Study Group Consensus Process.Ponsioen CY, Assis DN, Boberg KM, Bowlus CL, Deneau M, Thorburn D, Aabakken L, Färkkilä M, Petersen B, Rupp C, Hübscher SG. Gastroenterology. 2021 Dec; 2021 Aug 10. PMID: 34384749.
- Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study.Efe C, Dhanasekaran R, Lammert C, Ebik B, Higuera-de la Tijera F, Aloman C, Rıza Calışkan A, Peralta M, Gerussi A, Massoumi H, Catana AM, Torgutalp M, Purnak T, Rigamonti C, Gomez Aldana AJ, Khakoo N, Kacmaz H, Nazal L, Frager S, Demir N, Irak K, Ellik ZM, Balaban Y, Atay K, Eren F, Cristoferi L, Batıbay E, Urzua Á, Snijders R, Kıyıcı M, Akyıldız M, Ekin N, Carr RM, Harputluoğlu M, Hatemi I, Mendizabal M, Silva M, Idilman R, Silveira M, Drenth JPH, Assis DN, Björnsson E, Boyer JL, Invernizzi P, Levy C, Schiano TD, Ridruejo E, Wahlin S. Hepatology. 2021 Jun. PMID: 33713486.
- Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine.Soroka CJ, Roberts SJ, Boyer JL, Assis DN. Semin Liver Dis. 2021 May; 2021 May 6. PMID: 33957696.
- Treatment of Metastatic Extramammary Paget Disease with Combination Ipilimumab and Nivolumab: A Case Report.Guercio BJ, Iyer G, Kidwai WZ, Lacouture ME, Ghafoor S, Rossi AM, Assis DN, Chen YB, Busam KJ, Janjigian YY, Jhaveri K, Feldman DR, Capozzi A, Figueroa V, Bajorin DF, Rosenberg JE, Hollmann TJ, Funt SA. Case Rep Oncol. 2021 Jan-Apr; 2021 Mar 12. PMID: 33790764.
- Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol.Ghonem NS, Auclair AM, Hemme CL, Gallucci GM, de la Rosa Rodriguez R, Boyer JL, Assis DN. Clin Pharmacol Ther. 2020 Dec; 2020 Jul 17. PMID: 32480421.
- A Systematic Review of Patient-Reported Outcomes in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.Kim HP, Lieber SR, Rogers ME, Moon AM, Loiselle M, Walker J, Assis DN, Safer R, Gomel R, Evon DM. Hepatol Commun. 2020 Oct; 2020 Aug 1. PMID: 33024919.
- Immunosuppressive Treatment Regimens in Autoimmune Hepatitis: Systematic Reviews and Meta-Analyses Supporting American Association for the Study of Liver Diseases Guidelines.Vierling JM, Kerkar N, Czaja AJ, Mack CL, Adams D, Assis DN, Manns MP, Mayo MJ, Nayfeh T, Majzoub AMM, Alzuabi MA, Ding J, Haffar S, Murad MH, Alsawas M. Hepatology. 2020 Aug. PMID: 32500593.
- Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases.Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. Hepatology. 2020 Aug; 2020 May 12. PMID: 31863477.
- Immunopathogenesis of Autoimmune Hepatitis.Assis DN. Clin Liver Dis (Hoboken). 2020 Mar; 2020 Apr 4. PMID: 32257125.
- Machine Learning in a Complex Disease: PREsTo Improves the Prognostication of Primary Sclerosing Cholangitis.Shung DL, Assis DN. Hepatology. 2020 Jan. PMID: 31850533.
- Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases.Lynch KD, Chapman RW, Keshav S, Montano-Loza AJ, Mason AL, Kremer AE, Vetter M, de Krijger M, Ponsioen CY, Trivedi P, Hirschfield G, Schramm C, Liu CH, Bowlus CL, Estes DJ, Pratt D, Hedin C, Bergquist A, de Vries AC, van der Woude CJ, Yu L, Assis DN, Boyer J, Ytting H, Hallibasic E, Trauner M, Marschall HU, Daretti LM, Marzioni M, Yimam KK, Perin N, Floreani A, Beretta-Piccoli BT, Rogers JK, Levy C. Clin Gastroenterol Hepatol. 2020 Jan; 2019 May 14. PMID: 31100458.
- The Contribution of B Cells in Autoimmune Liver Diseases.Taylor SA, Assis DN, Mack CL. Semin Liver Dis. 2019 Nov; 2019 Jun 21. PMID: 31226726.
- Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile.Soroka CJ, Assis DN, Alrabadi LS, Roberts S, Cusack L, Jaffe AB, Boyer JL. Hepatology. 2019 Sep; 2019 Mar 13. PMID: 30561836.
- Clinical utility of genomic analysis in adults with idiopathic liver disease.Hakim A, Zhang X, DeLisle A, Oral EA, Dykas D, Drzewiecki K, Assis DN, Silveira M, Batisti J, Jain D, Bale A, Mistry PK, Vilarinho S. J Hepatol. 2019 Jun; 2019 Apr 15. PMID: 31000363.
- Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies.Soroka CJ, Assis DN, Boyer JL. Methods Mol Biol. 2019. PMID: 31016667.
- Histologic features of autoimmune hepatitis: a critical appraisal.Gurung A, Assis DN, McCarty TR, Mitchell KA, Boyer JL, Jain D. Hum Pathol. 2018 Dec; 2018 Jul 21. PMID: 30041025.
- Chronic Complications of Cholestasis: Evaluation and Management.Assis DN. Clin Liver Dis. 2018 Aug; 2018 May 28. PMID: 30259851.
- Gallbladder and bile duct disease in Cystic Fibrosis.Assis DN, Debray D. J Cyst Fibros. 2017 Nov. PMID: 28986023.
- Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot Study.Assis DN, Abdelghany O, Cai SY, Gossard AA, Eaton JE, Keach JC, Deng Y, Setchell KD, Ciarleglio M, Lindor KD, Boyer JL. J Clin Gastroenterol. 2017 Feb. PMID: 27428727.
- A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients.Assis DN, Takahashi H, Leng L, Zeniya M, Boyer JL, Bucala R. Dig Dis Sci. 2016 Dec; 2016 Oct 1. PMID: 27696094.
- Gastrointestinal Disorders in Cystic Fibrosis.Assis DN, Freedman SD. Clin Chest Med. 2016 Mar; 2015 Dec 24. PMID: 26857772.
- Fibrates and cholestasis.Ghonem NS, Assis DN, Boyer JL. Hepatology. 2015 Aug; 2015 Mar 23. PMID: 25678132.
- Editorial: environmental risk factors for PSC with and without IBD--the story unfolds.Assis DN, Levy C. Aliment Pharmacol Ther. 2015 Jun. PMID: 25939466.
- The role of macrophage migration inhibitory factor in autoimmune liver disease.Assis DN, Leng L, Du X, Zhang CK, Grieb G, Merk M, Garcia AB, McCrann C, Chapiro J, Meinhardt A, Mizue Y, Nikolic-Paterson DJ, Bernhagen J, Kaplan MM, Zhao H, Boyer JL, Bucala R. Hepatology. 2014 Feb; 2013 Dec 20. PMID: 23913513.
- New pharmacotherapy for hepatitis C.Assis DN, Lim JK. Clin Pharmacol Ther. 2012 Sep; 2012 Aug 1. PMID: 22850602.
- Successful treatment of a bleeding umbilical varix by percutaneous umbilical vein embolization with sclerotherapy.Assis DN, Pollak J, Schilsky ML, Emre S. J Clin Gastroenterol. 2012 Feb. PMID: 21897280.
- Testing and management of thrombocytopenia and coagulopathy in the pre- and postliver transplant patient.Assis DN, Schilsky ML. Minerva Gastroenterol Dietol. 2010 Sep. PMID: 21037549.
James Lorenzen Boyer, MD, FACEP
Shi-Ying Cai, DSc
Chuhan Chung, MD
Luca Fabris, MD, PhD
James J Farrell, MBChB
Romina Fiorotto, PhD
Guadalupe Garcia-Tsao, MD
Fred Gorelick, MD
Mateus Tavares Guerra, PhD
Matija Hedl, PhD
Avlin Barlow Imaeda, MD, PhD
Yasuko Iwakiri, PhD
Priya Arvind Jamidar, FACG, FASGE, MBChB
Loren Laine, MD
Annmarie Huysman Liapakis, MD
Joseph K Lim, MD
- AGA Clinical Practice Update on Management of Portal Vein Thrombosis in Patients With Cirrhosis: Expert Review.Davis JPE, Lim JK, Francis FF, Ahn J. Gastroenterology. 2025 Feb; 2024 Dec 20. PMID: 39708000.
- Hepatitis Delta Virus Testing, Prevalence, and Liver-Related Outcomes Among US Veterans With Chronic Hepatitis B.Wong RJ, Yang Z, Jou JH, John BV, Lim JK, Cheung R. Gastro Hep Adv. 2025; 2024 Oct 25. PMID: 39906477.
- Advanced Liver Fibrosis Predicts Liver Outcomes in Biopsy-proven Metabolic Dysfunction-associated Steatotic Liver Disease: A U.S.-based Single-center Retrospective Cohort Study.Lam R, Jain D, Deng Y, Acharya E, Lim JK. J Clin Transl Hepatol. 2024 Dec 28; 2024 Oct 17. PMID: 39649030.
- Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status.Lo Re V 3rd, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Torgersen J. Pharmacoepidemiol Drug Saf. 2024 Dec. PMID: 39662972.
- Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis.Ilagan-Ying YC, Gordon KS, Tate JP, Lim JK, Torgersen J, Lo Re V 3rd, Justice AC, Taddei TH. JAMA Netw Open. 2024 Nov 4; 2024 Nov 4. PMID: 39504020.
- Outcomes of a 1-Year Pilot Study Implementing Universal Hepatitis Delta Virus Testing Among Veterans With Chronic Hepatitis B.Wong RJ, Liao M, Chen Y, Kwan M, Lee JH, Jou JH, Lim JK, Cheung R. J Viral Hepat. 2024 Nov; 2024 Aug 5. PMID: 39101377.
- Unmet needs in the clinical management of chronic hepatitis B infection.Block PD, Lim JK. J Formos Med Assoc. 2024 Aug 17; 2024 Aug 17. PMID: 39155176.
- Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.Torgersen J, Mezochow AK, Newcomb CW, Carbonari DM, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Lo Re V 3rd. JAMA Intern Med. 2024 Aug 1. PMID: 38913369.
- Identification of hepatic steatosis among persons with and without HIV using natural language processing.Torgersen J, Skanderson M, Kidwai-Khan F, Carbonari DM, Tate JP, Park LS, Bhattacharya D, Lim JK, Taddei TH, Justice AC, Lo Re V 3rd. Hepatol Commun. 2024 Jul 1; 2024 Jun 19. PMID: 38896066.
- Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practice.Njei B, Lim JK. Aliment Pharmacol Ther. 2024 Jul; 2024 Apr 21. PMID: 38643498.
- Association of Baseline Hepatitis B Virus DNA and On-Treatment Risk of Cirrhosis and Hepatocellular Carcinoma.Yang Z, Cheung RC, Jou JH, Lim JK, Lim YS, Wong RJ. Gastroenterology Res. 2024 Jun; 2024 Jun 29. PMID: 38993547.
- Management of HBV reactivation: Challenges and opportunities.Mezzacappa C, Lim JK. Clin Liver Dis (Hoboken). 2024 Jan-Jun; 2024 May 8. PMID: 38720793.
- Prevalence and characteristics of hepatitis delta virus infection in patients with hepatitis B in the United States: An analysis of the All-Payer Claims Database.Gish RG, Jacobson IM, Lim JK, Waters-Banker C, Kaushik A, Kim C, Cyhaniuk A, Wong RJ. Hepatology. 2024 May 1; 2023 Nov 16. PMID: 37976395.
- An explainable machine learning model for prediction of high-risk nonalcoholic steatohepatitis.Njei B, Osta E, Njei N, Al-Ajlouni YA, Lim JK. Sci Rep. 2024 Apr 13; 2024 Apr 13. PMID: 38615137.
- Clinical Liver Disease: Legacy of innovation in hepatology education.Lim JK. Clin Liver Dis (Hoboken). 2024 Jan-Jun; 2024 Apr 2. PMID: 38567095.
- Advances in discovery of novel investigational agents for functional cure of chronic hepatitis B: A comprehensive review of phases II and III therapeutic agents.Lam R, Lim JK. World J Hepatol. 2024 Mar 27. PMID: 38577537.
- Hepatitis C in Black Individuals in the US: A Review.Falade-Nwulia O, Kelly SM, Amanor-Boadu S, Nnodum BN, Lim JK, Sulkowski M. JAMA. 2023 Dec 12. PMID: 37943553.
- Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.Malhi H, Brown RS Jr, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Clin Liver Dis (Hoboken). 2023 Dec; 2023 Nov 9. PMID: 38143807.
- Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.Malhi H, Brown RS Jr, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Hepatology. 2023 Dec 1; 2023 Nov 9. PMID: 37941421.
- Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.Malhi H, Brown RS Jr, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Liver Transpl. 2023 Dec 1; 2023 Nov 9. PMID: 37941408.
- Precipitous changes in nomenclature and definitions-NAFLD becomes SLD: Implications for and expectations of AASLD journals.Malhi H, Brown RS Jr, Lim JK, Reau N, Tapper EB, Wong CC, Gores GJ. Hepatol Commun. 2023 Nov 1; 2023 Nov 9. PMID: 37941420.
- Clinical and Histopathological Discoveries in Patients with Hepatic Injury and Cholangiopathy Who Have Died of COVID-19: Insights and Opportunities for Intervention.Lim JK, Njei B. Hepat Med. 2023; 2023 Oct 4. PMID: 37814605.
- Screening, Diagnosis, and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD): Application of Society Guidelines to Clinical Practice.Ilagan-Ying YC, Banini BA, Do A, Lam R, Lim JK. Curr Gastroenterol Rep. 2023 Oct; 2023 Sep 28. PMID: 37768417.
- AGA Clinical Practice Update on the Role of Noninvasive Biomarkers in the Evaluation and Management of Nonalcoholic Fatty Liver Disease: Expert Review.Wattacheril JJ, Abdelmalek MF, Lim JK, Sanyal AJ. Gastroenterology. 2023 Oct; 2023 Aug 4. PMID: 37542503.
- Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV.Torgersen J, Akers S, Huo Y, Terry JG, Carr JJ, Ruutiainen AT, Skanderson M, Levin W, Lim JK, Taddei TH, So-Armah K, Bhattacharya D, Rentsch CT, Shen L, Carr R, Shinohara RT, McClain M, Freiberg M, Justice AC, Lo Re V 3rd. Pharmacoepidemiol Drug Saf. 2023 Oct; 2023 Jun 8. PMID: 37276449.
- Exercise Does Not Independently Improve Histological Outcomes in Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Chen G, Banini BA, Do A, Gunderson C, Zaman S, Lim JK. Genes (Basel). 2023 Sep 17; 2023 Sep 17. PMID: 37761951.
- Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012-2016.Kim J, Newcomb CW, Carbonari M, Torgersen J, Althoff KN, Kitahata MM, Klein MB, Moore RD, Reddy KR, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Lim JK, Gill MJ, Chew K, Sterling TR, Hull M, Seaberg EC, Kirk GD, Coburn SB, Lang R, McGinnis KA, Gebo KA, Napravnik S, Kim HN, Lo Re V 3rd. PLoS One. 2023; 2023 Sep 1. PMID: 37656704.
- Lean NAFLD is associated with adverse liver events and mortality: Moving beyond BMI.Do A, Lim JK. Hepatology. 2023 Jul 1; 2023 Mar 13. PMID: 36896961.
- Chronic Hepatitis B Virus: What an Internist Needs to Know: Serologic Diagnosis, Treatment Options, and Hepatitis B Virus Reactivation.Block PD, Lim JK. Med Clin North Am. 2023 May; 2023 Feb 20. PMID: 37001946.
- Screening for Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.Lim JK. Gastroenterol Hepatol (N Y). 2023 Mar. PMID: 37706112.
- AGA Clinical Practice Update on Diagnosis and Management of Acute Hepatic Porphyrias: Expert Review.Wang B, Bonkovsky HL, Lim JK, Balwani M. Gastroenterology. 2023 Mar; 2023 Jan 13. PMID: 36642627.
- Reply.Long MT, Noureddin M, Lim JK. Gastroenterology. 2023 Mar; 2022 Nov 13. PMID: 36379247.
- Tailoring stepwise treatment for Budd-Chiari syndrome: insights from the Asian Pacific Association for the Study of the Liver (APASL) consensus guidance.Haque LY, Lim JK. Hepatobiliary Surg Nutr. 2023 Feb 28; 2023 Jan 9. PMID: 36860254.
- The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review.Chen G, Banini B, Do A, Lim JK. Clin Mol Hepatol. 2023 Feb; 2022 Dec 14. PMID: 36517000.
- Treating Hepatitis C in Individuals With Previous Incarceration: The Veterans Health Administration, 2012-2019.Hawks L, Wang EA, Butt AA, Crystal S, Keith McInnes D, Re VL, Cartwright EJ, Puglisi LB, Haque LYK, Lim JK, Justice AC, McGinnis KA. Am J Public Health. 2023 Feb; 2022 Dec 8. PMID: 36480765.
- Simplifying the Diagnosis and Treatment of Hepatitis B Infection: One Step for Addressing Deficits in the Care Cascade, One Leap for Elimination.Rabiee A, Lim JK. Gastro Hep Adv. 2023; 2022 Dec 15. PMID: 39132614.
- Left Atrial Mechanics and Diastolic Function Among People Living With Human Immunodeficiency Virus (from the Veterans Aging Cohort Study).Berg CJ, Patel B, Reynolds M, Tuzovic M, Chew KW, Sico JJ, Bhattacharya D, Butt AA, Lim JK, Bedimo RJ, Brown ST, Gottdiener JS, Warner AL, Freiberg MS, So-Armah KA, Nguyen KL. Am J Cardiol. 2023 Jan 1; 2022 Nov 5. PMID: 36343446.
- Association Between Alcohol Use Disorder and Receipt of Direct-Acting Antiviral Hepatitis C Virus Treatment.Haque LY, Fiellin DA, Tate JP, Esserman D, Bhattacharya D, Butt AA, Crystal S, Edelman EJ, Gordon AJ, Lim JK, Tetrault JM, Williams EC, Bryant K, Cartwright EJ, Rentsch CT, Justice AC, Lo Re V 3rd, McGinnis KA. JAMA Netw Open. 2022 Dec 1; 2022 Dec 1. PMID: 36515952.
- Non-responders to sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection.Karimi-Sari H, Rezaee-Zavareh MS, Falade-Nwulia O, Lim JK. J Hepatol. 2022 Oct; 2022 Jul 5. PMID: 35798132.
- Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis.Suri J, Borja S, Lim JK. World J Gastroenterol. 2022 Sep 21. PMID: 36188726.
- AGA Clinical Practice Update: Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Lean Individuals: Expert Review.Long MT, Noureddin M, Lim JK. Gastroenterology. 2022 Sep; 2022 Jul 14. PMID: 35842345.
- Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak.Zhang LY, Huang LS, Yue YH, Fawaz R, Lim JK, Fan JG. J Clin Transl Hepatol. 2022 Jun 28; 2022 Jun 22. PMID: 35836761.
- NASH and the Gut Microbiome: Implications for New Therapies.Tsay CJ, Lim JK. Clin Liver Dis (Hoboken). 2022 Mar; 2022 Jan 28. PMID: 35355843.
- The ALT upper reference interval debate: Blame it on the alcohol.Vera MA, Koch CD, Liapakis A, Lim JK, El-Khoury JM. Clin Chim Acta. 2022 Feb 1; 2021 Dec 29. PMID: 34973184.
- Oral Cyanobacteria and Hepatocellular Carcinoma.Hernandez BY, Zhu X, Risch HA, Lu L, Ma X, Irwin ML, Lim JK, Taddei TH, Pawlish KS, Stroup AM, Brown R, Wang Z, Wong LL, Yu H. Cancer Epidemiol Biomarkers Prev. 2022 Jan; 2021 Oct 25. PMID: 34697061.
- Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study.Wang Z, Budhu AS, Shen Y, Wong LL, Hernandez BY, Tiirikainen M, Ma X, Irwin ML, Lu L, Zhao H, Lim JK, Taddei T, Mishra L, Pawlish K, Stroup A, Brown R, Nguyen MH, Koshiol J, Hernandez MO, Forgues M, Yang HI, Lee MH, Huang YH, Iwasaki M, Goto A, Suzuki S, Matsuda K, Tanikawa C, Kamatani Y, Mann D, Guarnera M, Shetty K, Thomas CE, Yuan JM, Khor CC, Koh WP, Risch H, Wang XW, Yu H. JGH Open. 2021 Dec; 2021 Nov 27. PMID: 34950780.
- Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation.Torgersen J, Newcomb CW, Carbonari DM, Rentsch CT, Park LS, Mezochow A, Mehta RL, Buchwalder L, Tate JP, Bräu N, Bhattacharya D, Lim JK, Taddei TH, Justice AC, Lo Re V 3rd. J Hepatol. 2021 Dec; 2021 Jul 29. PMID: 34333102.
- Care of the Patient With Abnormal Liver Test Results.Tran AN, Lim JK. Ann Intern Med. 2021 Sep; 2021 Sep 14. PMID: 34516271.
- AGA Rapid Review and Guideline for SARS-CoV2 Testing and Endoscopy Post-Vaccination: 2021 Update.Sultan S, Siddique SM, Singh S, Altayar O, Caliendo AM, Davitkov P, Feuerstein JD, Kaul V, Lim JK, Mustafa RA, Falck-Ytter Y, Inadomi JM. Gastroenterology. 2021 Sep; 2021 May 21. PMID: 34029569.
- Risk of HCC With Hepatitis B Viremia Among HIV/HBV-Coinfected Persons in North America.Kim HN, Newcomb CW, Carbonari DM, Roy JA, Torgersen J, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Sun J, Hull M, Gill MJ, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Lo Re V 3rd. Hepatology. 2021 Sep; 2021 Jun 22. PMID: 33780007.
- The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.Sellers CM, Uhlig J, Ludwig JM, Pollak JS, Taddei TH, Stein SM, Lim JK, Kim HS. Cancer Med. 2021 Aug; 2021 Jul 28. PMID: 34318618.
- Association between HIV and incident pulmonary hypertension in US Veterans: a retrospective cohort study.Duncan MS, Alcorn CW, Freiberg MS, So-Armah K, Patterson OV, DuVall SL, Crothers KA, Re VL 3rd, Butt AA, Lim JK, Kim JW, Tindle HA, Justice AC, Brittain EL. Lancet Healthy Longev. 2021 Jul; 2021 Jun 16. PMID: 34296203.
- Willingness to participate in research among black patients with liver disease: A national cross-sectional study.McGuire FH, André K, Bradsher ML, Harrison D, Sterling RK, Reddy KR, Serper M, Golin CE, Reau N, Lim JK, Nelson DR, Sarkar S, Evon DM. J Viral Hepat. 2021 Jul; 2021 Apr 26. PMID: 33665897.
- Patient-reported outcomes 12 months after hepatitis C treatment with direct-acting antivirals: Results from the PROP UP study.Serper M, Evon DM, Amador J, Stewart PW, Sarkar S, Lok AS, Sterling RK, Reeve BB, Golin CE, Rajender Reddy K, Lim JK, Reau N, Nelson DR, Di Bisceglie AM, Fried MW. Liver Int. 2021 Apr; 2021 Jan 22. PMID: 33387381.
- AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review.Dougan M, Wang Y, Rubio-Tapia A, Lim JK. Gastroenterology. 2021 Mar; 2020 Oct 17. PMID: 33080231.
- Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system.Ilagan-Ying YC, Xu J, Lim JK, Do A. Eur J Gastroenterol Hepatol. 2021 Mar 1. PMID: 32433419.
- Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.Sun J, Althoff KN, Jing Y, Horberg MA, Buchacz K, Gill MJ, Justice AC, Rabkin CS, Goedert JJ, Sigel K, Cachay E, Park L, Lim JK, Kim HN, Lo Re V 3rd, Moore R, Sterling T, Peters MG, Achenbach CJ, Silverberg M, Thorne JE, Mayor AM, Crane HM, Kitahata MM, Klein M, Kirk GD. JAMA Netw Open. 2021 Feb 1; 2021 Feb 1. PMID: 33595662.
- AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.Younossi ZM, Corey KE, Lim JK. Gastroenterology. 2021 Feb; 2020 Dec 9. PMID: 33307021.
- Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints.Do A, Ilagan-Ying YC, Mehal WZ, Lim JK. Expert Opin Drug Discov. 2021 Feb; 2020 Oct 22. PMID: 33086894.
- Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B.Lim JK, Chang AY, Zaman A, Martin P, Fernandez-Rodriguez CM, Korkmaz M, Rossi S, Ford JM, Noonan T, Cooney E, Navarro V, Colombato L. J Clin Transl Hepatol. 2020 Dec 28; 2020 Oct 10. PMID: 33447520.
- Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Bräu N, Brown ST, Taddei TH, Justice AC, Lo Re V 3rd. J Acquir Immune Defic Syndr. 2020 Dec 15. PMID: 33185999.
- Waking Up the Sleeping Giant: Treatment of Hepatitis B Reactivation During Immunosuppressive Drug Therapy.Saffo S, Lim JK. Clin Liver Dis (Hoboken). 2020 Nov; 2020 Dec 10. PMID: 33318788.
- AGA Institute Rapid Review and Recommendations on the Role of Pre-Procedure SARS-CoV-2 Testing and Endoscopy.Sultan S, Siddique SM, Altayar O, Caliendo AM, Davitkov P, Feuerstein JD, Francis D, Inadomi JM, Lim JK, Falck-Ytter Y, Mustafa RA. Gastroenterology. 2020 Nov; 2020 Jul 28. PMID: 32735862.
- HIV- and HCV-specific markers and echocardiographic pulmonary artery systolic pressure among United States veterans.Zola CE, Duncan MS, So-Armah K, Crothers KA, Butt AA, Gibert CL, Kim JWW, Lim JK, Re VL 3rd, Tindle HA, Freiberg MS, Brittain EL. Sci Rep. 2020 Oct 30; 2020 Oct 30. PMID: 33127959.
- Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.Do A, Esserman DA, Krishnan S, Lim JK, Taddei TH, Hauser RG 3rd, Tate JP, Re VL 3rd, Justice AC. J Gen Intern Med. 2020 Oct. PMID: 33021712.
- Abnormal Liver Tests in COVID-19: A Retrospective Observational Cohort Study of 1,827 Patients in a Major U.S. Hospital Network.Hundt MA, Deng Y, Ciarleglio MM, Nathanson MH, Lim JK. Hepatology. 2020 Oct. PMID: 32725890.
- Prevalence of Chronic Hepatitis B Virus Infection in the United States.Lim JK, Nguyen MH, Kim WR, Gish R, Perumalswami P, Jacobson IM. Am J Gastroenterol. 2020 Sep. PMID: 32483003.
- DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.Verna EC, Morelli G, Terrault NA, Lok AS, Lim JK, Di Bisceglie AM, Zeuzem S, Landis CS, Kwo P, Hassan M, Manns MP, Vainorius M, Akushevich L, Nelson DR, Fried MW, Reddy KR. J Hepatol. 2020 Sep; 2020 Mar 31. PMID: 32243960.
- Evaluating the Therapeutic Potential of Cenicriviroc in the Treatment of Nonalcoholic Steatohepatitis with Fibrosis: A Brief Report on Emerging Data.Diaz Soto MP, Lim JK. Hepat Med. 2020; 2020 Aug 13. PMID: 32884369.
- Budd-Chiari Syndrome: An Uncommon Cause of Chronic Liver Disease that Cannot Be Missed.Haque LYK, Lim JK. Clin Liver Dis. 2020 Aug; 2020 Jun 2. PMID: 32620283.
- Spotlight: COVID-19 PPE and Endoscopy.Siddique SM, Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Falck-Ytter Y, El-Serag HB. Gastroenterology. 2020 Aug; 2020 Jun 23. PMID: 32590006.
- AGA Rapid Recommendations for Gastrointestinal Procedures During the COVID-19 Pandemic.Sultan S, Lim JK, Altayar O, Davitkov P, Feuerstein JD, Siddique SM, Falck-Ytter Y, El-Serag HB. Gastroenterology. 2020 Aug; 2020 Apr 1. PMID: 32247018.
- Management of Hepatitis C in Special Populations: HIV Coinfection, Renal Disease, and Decompensated Cirrhosis.Lim JK. Clin Liver Dis (Hoboken). 2020 Jul; 2020 Jul 21. PMID: 32714521.
- AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, El-Serag HB. Gastroenterology. 2020 Jul; 2020 May 11. PMID: 32407808.
- Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.Do A, Esserman DA, Krishnan S, Lim JK, Taddei TH, Hauser RG 3rd, Tate JP, Re VL 3rd, Justice AC. J Gen Intern Med. 2020 Jul; 2020 Apr 27. PMID: 32342483.
- HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Gibert CL, Bräu N, Brown ST, Roy JA, Taddei TH, Justice AC, Lo Re V. J Natl Cancer Inst. 2020 Jul 1. PMID: 31687755.
- AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.Singal AG, Lim JK, Kanwal F. Clin Liver Dis (Hoboken). 2020 Jun; 2020 Jun 30. PMID: 32617150.
- Hepatitis C: How Good Are Real-Life Data and Do Generics Work.Tran AN, Lim JK. Gastroenterol Clin North Am. 2020 Jun; 2020 Mar 29. PMID: 32389363.
- Direct-Acting Antivirals Improve Overall Survival in Interventional Oncology Patients with Hepatitis C and Hepatocellular Carcinoma.Kamp WM, Sellers CM, Stein S, Lim JK, Kim HS. J Vasc Interv Radiol. 2020 Jun; 2020 May 4. PMID: 32376182.
- Pathophysiology of Hepatic Encephalopathy.Jaffe A, Lim JK, Jakab SS. Clin Liver Dis. 2020 May; 2020 Feb 19. PMID: 32245525.
- AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.Loomba R, Lim JK, Patton H, El-Serag HB. Gastroenterology. 2020 May; 2020 Jan 30. PMID: 32006545.
- Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study.Shen Y, Risch H, Lu L, Ma X, Irwin ML, Lim JK, Taddei T, Pawlish K, Stroup A, Brown R, Wang Z, Jia W, Wong L, Mayne ST, Yu H. Cancer Causes Control. 2020 Apr; 2020 Feb 14. PMID: 32060838.
- Medication Non-adherence in a Prospective, Multi-center Cohort Treated with Hepatitis C Direct-Acting Antivirals.Serper M, Evon DM, Stewart PW, Lok AS, Amador J, Reeve BB, Golin CE, Fried MW, Reddy KR, Sterling RK, Sarkar S, Di Bisceglie AM, Lim JK, Nelson DR, Reau N. J Gen Intern Med. 2020 Apr; 2019 Oct 28. PMID: 31659661.
- Assessing the Effectiveness of Strategies in US Birth Cohort Screening for Hepatitis C Infection.Tsay CJ, Lim JK. J Clin Transl Hepatol. 2020 Mar 28; 2020 Mar 24. PMID: 32274343.
- FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C.So-Armah KA, Lim JK, Lo Re V 3rd, Tate JP, Chang CH, Butt AA, Gibert CL, Rimland D, Marconi VC, Goetz MB, Ramachandran V, Brittain E, Long M, Nguyen KL, Rodriguez-Barradas MC, Budoff MJ, Tindle HA, Samet JH, Justice AC, Freiberg MS. Prog Cardiovasc Dis. 2020 Mar-Apr; 2020 Feb 15. PMID: 32068085.
- Reply to: "Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH)".Evon DM, Sarkar S, Amador J, Lok AS, Sterling RK, Stewart PW, Reeve BB, Serper M, Reau N, Reddy KR, Di Bisceglie AM, Nelson DR, Golin CE, Lim JK, Fried MW. J Hepatol. 2020 Mar; 2019 Dec 27. PMID: 31889556.
- Liver fibrosis and accelerated immune dysfunction (immunosenescence) among HIV-infected Russians with heavy alcohol consumption - an observational cross-sectional study.So-Armah K, Freiberg M, Cheng D, Lim JK, Gnatienko N, Patts G, Doyle M, Fuster D, Lioznov D, Krupitsky E, Samet J. BMC Gastroenterol. 2019 Dec 31; 2019 Dec 31. PMID: 31892306.
- Impact of Direct Acting Antivirals on Survival in Patients with Chronic Hepatitis C and Hepatocellular Carcinoma.Kamp WM, Sellers CM, Stein S, Lim JK, Kim HS. Sci Rep. 2019 Nov 19; 2019 Nov 19. PMID: 31745132.
- Hepatitis B Virus Reactivation in the Setting of Immunosuppressive Drug Therapy.Su J, Lim JK. Gastroenterol Hepatol (N Y). 2019 Nov. PMID: 31802984.
- AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review.Bowlus CL, Lim JK, Lindor KD. Clin Gastroenterol Hepatol. 2019 Nov; 2019 Jul 12. PMID: 31306801.
- Increasing contribution of non-alcoholic fatty liver disease to hepatocellular carcinoma incidence and mortality in U.S. Medicare.Wong CR, Lim JK. Hepatobiliary Surg Nutr. 2019 Oct. PMID: 31673540.
- Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET Analysis.Radhakrishnan K, Di Bisceglie AM, Reddy KR, Lim JK, Levitsky J, Hassan MA, Darling JM, Feld JJ, Akushevich L, Vainorius M, Nelson DR, Fried MW, Brown RS Jr, Terrault NA. Hepatol Commun. 2019 Oct; 2019 Aug 7. PMID: 31592494.
- The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance.Sellers CM, Uhlig J, Ludwig JM, Taddei T, Stein SM, Lim JK, Kim HS. Cancer Med. 2019 Oct; 2019 Aug 22. PMID: 31436905.
- Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.Lo Re V 3rd, Newcomb CW, Carbonari DM, Roy JA, Althoff KN, Kitahata MM, Reddy KR, Lim JK, Silverberg MJ, Mayor AM, Horberg MA, Cachay ER, Kirk GD, Hull M, Gill J, Sterling TR, Kostman JR, Peters MG, Moore RD, Klein MB, Kim HN. J Acquir Immune Defic Syndr. 2019 Sep 1. PMID: 31107304.
- Patient-reported symptoms during and after direct-acting antiviral therapies for chronic hepatitis C: The PROP UP study.Evon DM, Sarkar S, Amador J, Lok AS, Sterling RK, Stewart PW, Reeve BB, Serper M, Reau N, Rajender Reddy K, Di Bisceglie AM, Nelson DR, Golin CE, Lim JK, Fried MW. J Hepatol. 2019 Sep; 2019 May 13. PMID: 31096006.
- AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.Singal AG, Lim JK, Kanwal F. Gastroenterology. 2019 Jun; 2019 Mar 13. PMID: 30878469.
- Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients.Maughan A, Sadigh K, Angulo-Diaz V, Mandimika C, Villanueva M, Lim JK, Ogbuagu O. BMC Infect Dis. 2019 May 3; 2019 May 3. PMID: 31053098.
- Comparison of the prevalence, severity, and risk factors for hepatic steatosis in HIV-infected and uninfected people.Torgersen J, So-Armah K, Freiberg MS, Goetz MB, Budoff MJ, Lim JK, Taddei T, Butt AA, Rodriguez-Barradas MC, Justice AC, Kostman JR, Lo Re V 3rd. BMC Gastroenterol. 2019 Apr 15; 2019 Apr 15. PMID: 30987601.
- Advancing Age and Comorbidity in a US Insured Population-Based Cohort of Patients With Chronic Hepatitis B.Nguyen MH, Lim JK, Burak Ozbay A, Fraysse J, Liou I, Meyer N, Dusheiko G, Gordon SC. Hepatology. 2019 Mar; 2019 Feb 11. PMID: 30175482.
- A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.Lee HM, Ahn J, Kim WR, Lim JK, Nguyen M, Pan CQ, Kim D, Mannalithara A, Te H, Trinh H, Chu D, Tran T, Woog J, Lok AS. Dig Dis Sci. 2019 Feb; 2018 Sep 20. PMID: 30238203.
Xavier Llor, MD, PhD
- Validation of the NCCN/Yale criteria for the identification of CDH1 pathogenic variant carriers.Lerner BA, Giner-Calabuig M, Carraway C, Richardson M, Krahn K, Susswein L, Nielsen SM, Karam R, Xicola RM, Llor X. J Med Genet. 2025 Jan 27; 2025 Jan 27. PMID: 39674581.
- Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In Oncology.Hodan R, Gupta S, Weiss JM, Axell L, Burke CA, Chen LM, Chung DC, Clayback KM, Felder S, Foda Z, Giardiello FM, Grady W, Gustafson S, Hagemann A, Hall MJ, Hampel H, Idos G, Joseph N, Kassem N, Katona B, Kelly K, Kieber-Emmons A, Kupfer S, Lang K, Llor X, Markowitz AJ, Prats MM, Niell-Swiller M, Outlaw D, Pirzadeh-Miller S, Samadder NJ, Shibata D, Stanich PP, Swanson BJ, Szymaniak BM, Welborn J, Wiesner GL, Yurgelun MB, Dwyer M, Darlow S, Diwan Z. J Natl Compr Canc Netw. 2024 Dec. PMID: 39689429.
- NCCN Guidelines® Insights: Colorectal Cancer Screening, Version 1.2024.Ness RM, Llor X, Abbass MA, Bishu S, Chen CT, Cooper G, Early DS, Friedman M, Fudman D, Giardiello FM, Glaser K, Gurudu S, Hall M, Huang LC, Issaka R, Katona B, Kidambi T, Lazenby AJ, Maratt J, Markowitz AJ, Marsano J, May FP, Mayer RJ, Olortegui K, Patel S, Peter S, Porter LD, Shafi M, Stanich PP, Terdiman J, Vu P, Weiss JM, Wood E, Cassara CJ, Sambandam V. J Natl Compr Canc Netw. 2024 Sep. PMID: 39236750.
- Systems approach to enhance Lynch syndrome diagnosis through tumour testing.Singh V, Mezzacappa C, Gershkovich P, Di Giovanna J, Ganzak A, Gibson J, Sinard J, Xicola RM, Llor X. J Med Genet. 2023 Jun; 2022 Sep 17. PMID: 36115663.
- Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto Rico.Perez-Mayoral J, Gonzalez-Pons M, Centeno-Girona H, Montes-Rodríguez IM, Soto-Salgado M, Suárez B, Rodríguez N, Colón G, Sevilla J, Jorge D, Llor X, Xicola RM, Toro DH, Tous-López L, Torres-Torres M, Reyes JS, López-Acevedo N, Goel A, Rodríguez-Quilichini S, Cruz-Correa M. Genes (Basel). 2023 Apr 11; 2023 Apr 11. PMID: 37107652.
- Simplified and more sensitive criteria for identifying individuals with pathogenic CDH1 variants.Lerner BA, Xicola RM, Rodriguez NJ, Karam R, Llor X. J Med Genet. 2023 Jan; 2022 Jan 25. PMID: 35078942.
- Mutational signature profiling classifies subtypes of clinically different mismatch-repair-deficient tumours with a differential immunogenic response potential.Giner-Calabuig M, De Leon S, Wang J, Fehlmann TD, Ukaegbu C, Gibson J, Alustiza-Fernandez M, Pico MD, Alenda C, Herraiz M, Carrillo-Palau M, Salces I, Reyes J, Ortega SP, Obrador-Hevia A, Cecchini M, Syngal S, Stoffel E, Ellis NA, Sweasy J, Jover R, Llor X, Xicola RM. Br J Cancer. 2022 Jun; 2022 Feb 23. PMID: 35197584.
- Colorectal Cancer Risk in Lynch Syndrome: Of Genes and More.Mezzacappa C, Llor X. Gastroenterology. 2022 Apr; 2021 Dec 1. PMID: 34863785.
- Molecular drivers of tumor progression in microsatellite stable APC mutation-negative colorectal cancers.Grant A, Xicola RM, Nguyen V, Lim J, Thorne C, Salhia B, Llor X, Ellis N, Padi M. Sci Rep. 2021 Dec 6; 2021 Dec 6. PMID: 34873211.
- xDEEP-MSI: Explainable Bias-Rejecting Microsatellite Instability Deep Learning System in Colorectal Cancer.Bustos A, Payá A, Torrubia A, Jover R, Llor X, Bessa X, Castells A, Carracedo Á, Alenda C. Biomolecules. 2021 Nov 29; 2021 Nov 29. PMID: 34944430.
- NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.Weiss JM, Gupta S, Burke CA, Axell L, Chen LM, Chung DC, Clayback KM, Dallas S, Felder S, Gbolahan O, Giardiello FM, Grady W, Hall MJ, Hampel H, Hodan R, Idos G, Kanth P, Katona B, Lamps L, Llor X, Lynch PM, Markowitz AJ, Pirzadeh-Miller S, Samadder NJ, Shibata D, Swanson BJ, Szymaniak BM, Wiesner GL, Wolf A, Yurgelun MB, Zakhour M, Darlow SD, Dwyer MA, Campbell M. J Natl Compr Canc Netw. 2021 Oct 15; 2021 Oct 15. PMID: 34666312.
- Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database.Cheng E, Blackburn HN, Ng K, Spiegelman D, Irwin ML, Ma X, Gross CP, Tabung FK, Giovannucci EL, Kunz PL, Llor X, Billingsley K, Meyerhardt JA, Ahuja N, Fuchs CS. JAMA Netw Open. 2021 Jun 1; 2021 Jun 1. PMID: 34132794.
- Exome sequencing of early-onset patients supports genetic heterogeneity in colorectal cancer.Fernández-Rozadilla C, Álvarez-Barona M, Quintana I, López-Novo A, Amigo J, Cameselle-Teijeiro JM, Roman E, Gonzalez D, Llor X, Bujanda L, Bessa X, Jover R, Balaguer F, Castells A, Castellví-Bel S, Capellá G, Carracedo A, Valle L, Ruiz-Ponte C. Sci Rep. 2021 May 27; 2021 May 27. PMID: 34045552.
- Dickkopf-2 regulates the stem cell marker LGR5 in colorectal cancer via HNF4α1.Shin JH, Jeong J, Choi J, Lim J, Dinesh RK, Braverman J, Hong JY, Maher SE, Amezcua Vesely MC, Kim W, Koo JH, Tang W, Wu D, Blackburn HN, Xicola RM, Llor X, Yilmaz O, Choi JM, Bothwell ALM. iScience. 2021 May 21; 2021 Apr 15. PMID: 33997693.
- Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing SMAD4/BMPR1A Variant.MacFarland SP, Ebrahimzadeh JE, Zelley K, Begum L, Bass LM, Brand RE, Dudley B, Fishman DS, Ganzak A, Karloski E, Latham A, Llor X, Plon S, Riordan MK, Scollon SR, Stadler ZK, Syngal S, Ukaegbu C, Weiss JM, Yurgelun MB, Brodeur GM, Mamula P, Katona BW. Cancer Prev Res (Phila). 2021 Feb; 2020 Oct 23. PMID: 33097490.
- Genetic Gastric Cancer Risk Syndromes.Lerner BA, Llor X. Curr Treat Options Gastroenterol. 2020 Dec; 2020 Oct 19. PMID: 33776403.
- AGA White Paper: Roadmap for the Future of Colorectal Cancer Screening in the United States.Melson JE, Imperiale TF, Itzkowitz SH, Llor X, Kochman ML, Grady WM, Schoen RE, Burke CA, Shaukat A, Rabeneck L, Ladabaum U, Bresalier R, Spiegel B, Yee J, Wang T, Lieberman D, Komanduri S, Muthusamy VR, Dey N. Clin Gastroenterol Hepatol. 2020 Nov; 2020 Jul 4. PMID: 32634626.
- NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020.Provenzale D, Ness RM, Llor X, Weiss JM, Abbadessa B, Cooper G, Early DS, Friedman M, Giardiello FM, Glaser K, Gurudu S, Halverson AL, Issaka R, Jain R, Kanth P, Kidambi T, Lazenby AJ, Maguire L, Markowitz AJ, May FP, Mayer RJ, Mehta S, Patel S, Peter S, Stanich PP, Terdiman J, Keller J, Dwyer MA, Ogba N. J Natl Compr Canc Netw. 2020 Oct 1; 2020 Oct 1. PMID: 33022639.
- Decreased copy-neutral loss of heterozygosity in African American colorectal cancers.Augustus GJ, Xicola RM, Llor X, Ellis NA. Genes Chromosomes Cancer. 2020 Aug; 2020 Apr 29. PMID: 32293075.
- Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria.Xicola RM, Li S, Rodriguez N, Reinecke P, Karam R, Speare V, Black MH, LaDuca H, Llor X. J Med Genet. 2019 Dec; 2019 Jul 11. PMID: 31296550.
- Lynch Syndrome: Widening the Net.Llor X. Gastroenterology. 2019 Nov; 2019 Oct 3. PMID: 31586568.
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.Gupta S, Provenzale D, Llor X, Halverson AL, Grady W, Chung DC, Haraldsdottir S, Markowitz AJ, Slavin TP Jr, Hampel H, Ness RM, Weiss JM, Ahnen DJ, Chen LM, Cooper G, Early DS, Giardiello FM, Hall MJ, Hamilton SR, Kanth P, Klapman JB, Lazenby AJ, Lynch PM, Mayer RJ, Mikkelson J, Peter S, Regenbogen SE, Dwyer MA, Ogba N. J Natl Compr Canc Netw. 2019 Sep 1. PMID: 31487681.
- Scoring colorectal cancer risk with an artificial neural network based on self-reportable personal health data.Nartowt BJ, Hart GR, Roffman DA, Llor X, Ali I, Muhammad W, Liang Y, Deng J. PLoS One. 2019; 2019 Aug 22. PMID: 31437221.
- Implication of DNA repair genes in Lynch-like syndrome.Xicola RM, Clark JR, Carroll T, Alvikas J, Marwaha P, Regan MR, Lopez-Giraldez F, Choi J, Emmadi R, Alagiozian-Angelova V, Kupfer SS, Ellis NA, Llor X. Fam Cancer. 2019 Jul. PMID: 30989425.
- Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.Xicola RM, Manojlovic Z, Augustus GJ, Kupfer SS, Emmadi R, Alagiozian-Angelova V, Triche T Jr, Salhia B, Carpten J, Llor X, Ellis NA. Carcinogenesis. 2018 Dec 13. PMID: 30239619.
- Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.Murcia O, Juárez M, Rodríguez-Soler M, Hernández-Illán E, Giner-Calabuig M, Alustiza M, Egoavil C, Castillejo A, Alenda C, Barberá V, Mangas-Sanjuan C, Yuste A, Bujanda L, Clofent J, Andreu M, Castells A, Llor X, Zapater P, Jover R. PLoS One. 2018; 2018 Sep 6. PMID: 30188916.
- Genetic testing for hereditary prostate cancer: Current status and limitations.Zhen JT, Syed J, Nguyen KA, Leapman MS, Agarwal N, Brierley K, Llor X, Hofstatter E, Shuch B. Cancer. 2018 Aug 1; 2018 Apr 18. PMID: 29669169.
- TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer.Murcia O, Jover R, Egoavil C, Perez-Carbonell L, Juárez M, Hernández-Illán E, Rojas E, Alenda C, Balaguer F, Andreu M, Llor X, Castells A, Boland CR, Goel A. Clin Cancer Res. 2018 Jun 15; 2018 Mar 13. PMID: 29535127.
- Race-dependent association of sulfidogenic bacteria with colorectal cancer.Yazici C, Wolf PG, Kim H, Cross TL, Vermillion K, Carroll T, Augustus GJ, Mutlu E, Tussing-Humphreys L, Braunschweig C, Xicola RM, Jung B, Llor X, Ellis NA, Gaskins HR. Gut. 2017 Nov; 2017 Feb 2. PMID: 28153960.
- Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer.Kandimalla R, Linnekamp JF, van Hooff S, Castells A, Llor X, Andreu M, Jover R, Goel A, Medema JP. Oncogenesis. 2017 Apr 3; 2017 Apr 3. PMID: 28368388.
- Building a Cancer Genetics and Prevention Program.Llor X. Clin Gastroenterol Hepatol. 2016 Nov; 2016 Aug 13. PMID: 27531499.
- Association of a let-7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC).Xicola RM, Bontu S, Doyle BJ, Rawson J, Garre P, Lee E, de la Hoya M, Bessa X, Clofent J, Bujanda L, Balaguer F, Castellví-Bel S, Alenda C, Jover R, Ruiz-Ponte C, Syngal S, Andreu M, Carracedo A, Castells A, Newcomb PA, Lindor N, Potter JD, Baron JA, Ellis NA, Caldes T, LLor X. Carcinogenesis. 2016 Aug; 2016 May 27. PMID: 27234654.
- Kinase-Dependent and -Independent Roles for PTK6 in Colon Cancer.Mathur PS, Gierut JJ, Guzman G, Xie H, Xicola RM, Llor X, Chastkofsky MI, Perekatt AO, Tyner AL. Mol Cancer Res. 2016 Jun; 2016 Mar 16. PMID: 26983689.
- A meta-analysis of MSI frequency and race in colorectal cancer.Ashktorab H, Ahuja S, Kannan L, Llor X, Ellis NA, Xicola RM, Laiyemo AO, Carethers JM, Brim H, Nouraie M. Oncotarget. 2016 Apr 23. PMID: 27120810.
- Efficacy of Adjuvant 5-Fluorouracil Therapy for Patients with EMAST-Positive Stage II/III Colorectal Cancer.Hamaya Y, Guarinos C, Tseng-Rogenski SS, Iwaizumi M, Das R, Jover R, Castells A, Llor X, Andreu M, Carethers JM. PLoS One. 2015; 2015 May 21. PMID: 25996601.
- Enrichment of inflammatory bowel disease and colorectal cancer risk variants in colon expression quantitative trait loci.Hulur I, Gamazon ER, Skol AD, Xicola RM, Llor X, Onel K, Ellis NA, Kupfer SS. BMC Genomics. 2015 Feb 27; 2015 Feb 27. PMID: 25766683.
- Excess of proximal microsatellite-stable colorectal cancer in African Americans from a multiethnic study.Xicola RM, Gagnon M, Clark JR, Carroll T, Gao W, Fernandez C, Mijic D, Rawson JB, Janoski A, Pusatcioglu CK, Rajaram P, Gluskin AB, Regan M, Chaudhry V, Abcarian H, Blumetti J, Cintron J, Melson J, Xie H, Guzman G, Emmadi R, Alagiozian-Angelova V, Kupfer SS, Braunschweig C, Ellis NA, Llor X. Clin Cancer Res. 2014 Sep 15; 2014 Jul 10. PMID: 25013126.
- Colorectal cancer: from the laboratory to the patient, a now indispensable step.Llor X. Rev Gastroenterol Mex. 2014 Apr-Jun. PMID: 24934514.
Amir Masoud, MBBS
- SPLIT-DOSE BOWEL PREPARATION IS SUPERIOR TO STRAIGHT-DOSE IN HOSPITALIZED PATIENTS UNDERGOING INPATIENT COLONOSCOPY.Magier S, Jahandideh D, Pourmorady J, Masoud A. Arq Gastroenterol. 2023 Jan-Mar. PMID: 37194778.
- Chronic opioid use is associated with obstructive and spastic disorders in the esophagus.Sanchez MJ, Olivier S, Gediklioglu F, Almeida M, Gaeta M, Nigro M, de la Rosa R, Nguyen M, Lalehzari M, Regala F, Njei B, Deng Y, Ciarleglio M, Masoud A. Neurogastroenterol Motil. 2022 Mar; 2021 Sep 16. PMID: 34532898.
- Effectiveness of esophagogastroduodenoscopy in changing treatment outcome in refractory gastro-esophageal reflux disease.Kwak YE, Saleh A, Abdelwahed A, Sanchez M, Masoud A. Scand J Gastroenterol. 2022 Jan; 2021 Oct 20. PMID: 34669534.
- Impact of COVID-19 on gastroenterology fellowship training: a multicenter analysis of endoscopy volumes.Paleti S, Sobani ZA, McCarty TR, Gutta A, Gremida A, Shah R, Nutalapati V, Bazerbachi F, Jesudoss R, Amin S, Okwara C, Kathi PR, Ahmed A, Gessel L, Hung K, Masoud A, Yu J, Mony S, Akshintala V, Jamil L, Nasereddin T, Kochhar G, Vyas N, Saligram S, Garg R, Sandhu D, Benrajab K, Konjeti R, Agnihotri A, Trivedi H, Grunwald M, Mayer I, Mohanty A, Rustagi T. Endosc Int Open. 2021 Oct; 2021 Sep 16. PMID: 34540553.
- Use of Proton Pump Inhibitors Increases Risk of Incident Kidney Stones.Simonov M, Abel EA, Skanderson M, Masoud A, Hauser RG, Brandt CA, Wilson FP, Laine L. Clin Gastroenterol Hepatol. 2021 Jan; 2020 Mar 6. PMID: 32147588.
- Burkitt lymphoma as a lead point for jejunojejunal intussusception in a human immunodeficiency virus patient.Sharma P, Balasingham S, Stawiarski K, Rahmani M, Costantino A, Sharma P, Xu M, Masoud A. Clin J Gastroenterol. 2017 Aug; 2017 May 18. PMID: 28523628.
Wajahat Zafar Mehal, PhD, MD
Thiruvengadam Muniraj, MD, MRCP
Michael Harris Nathanson, MD, PhD
Hamita Sachar, MD
Michael Schilsky, MD
Marina Silveira, MD
Carol J Soroka, PhD
- Human vascularized bile duct-on-a chip: a multi-cellular micro-physiological system for studying cholestatic liver disease.Du Y, de Jong IEM, Gupta K, Waisbourd-Zinman O, Har-Zahav A, Soroka CJ, Boyer JL, Llewellyn J, Liu C, Naji A, Polacheck WJ, Wells RG. Biofabrication. 2023 Oct 20; 2023 Oct 20. PMID: 37820623.
- Bile formation and secretion: An update.Boyer JL, Soroka CJ. J Hepatol. 2021 Jul; 2021 Feb 20. PMID: 33617926.
- Role of Biliary Organoids in Cholestasis Research and Regenerative Medicine.Soroka CJ, Roberts SJ, Boyer JL, Assis DN. Semin Liver Dis. 2021 May; 2021 May 6. PMID: 33957696.
- Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis.Cai SY, Yu D, Soroka CJ, Wang J, Boyer JL. J Hepatol. 2021 Mar; 2020 Oct 9. PMID: 33039404.
- Organic Solute Transporter Alpha Deficiency: A Disorder With Cholestasis, Liver Fibrosis, and Congenital Diarrhea.Gao E, Cheema H, Waheed N, Mushtaq I, Erden N, Nelson-Williams C, Jain D, Soroka CJ, Boyer JL, Khalil Y, Clayton PT, Mistry PK, Lifton RP, Vilarinho S. Hepatology. 2020 May. PMID: 31863603.
- Bile-Derived Organoids From Patients With Primary Sclerosing Cholangitis Recapitulate Their Inflammatory Immune Profile.Soroka CJ, Assis DN, Alrabadi LS, Roberts S, Cusack L, Jaffe AB, Boyer JL. Hepatology. 2019 Sep; 2019 Mar 13. PMID: 30561836.
- Patient-Derived Organoids from Human Bile: An In Vitro Method to Study Cholangiopathies.Soroka CJ, Assis DN, Boyer JL. Methods Mol Biol. 2019. PMID: 31016667.
- Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response.Cai SY, Ouyang X, Chen Y, Soroka CJ, Wang J, Mennone A, Wang Y, Mehal WZ, Jain D, Boyer JL. JCI Insight. 2017 Mar 9; 2017 Mar 9. PMID: 28289714.
- CFTR-associated ligand is a negative regulator of Mrp2 expression.Li M, Soroka CJ, Harry K, Boyer JL. Am J Physiol Cell Physiol. 2017 Jan 1; 2016 Nov 9. PMID: 27834195.
- Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid-fed mouse model of cholestasis.Kulkarni SR, Soroka CJ, Hagey LR, Boyer JL. Hepatology. 2016 Dec; 2016 Oct 28. PMID: 27639250.
- A Novel Di-Leucine Motif at the N-Terminus of Human Organic Solute Transporter Beta Is Essential for Protein Association and Membrane Localization.Xu S, Soroka CJ, Sun AQ, Backos DS, Mennone A, Suchy FJ, Boyer JL. PLoS One. 2016; 2016 Jun 28. PMID: 27351185.
- Na(+) /H(+) exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury.Li M, Mennone A, Soroka CJ, Hagey LR, Ouyang X, Weinman EJ, Boyer JL. Hepatology. 2015 Oct; 2015 Aug 22. PMID: 26108984.
- Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.Soroka CJ, Boyer JL. Mol Aspects Med. 2014 Jun; 2013 May 15. PMID: 23685087.
- Altered expression and function of canalicular transporters during early development of cholestatic liver injury in Abcb4-deficient mice.Cai SY, Mennone A, Soroka CJ, Boyer JL. Am J Physiol Gastrointest Liver Physiol. 2014 Apr 15; 2014 Jan 30. PMID: 24481602.
- All-trans-retinoic acid improves cholestasis in α-naphthylisothiocyanate-treated rats and Mdr2-/- mice.Cai SY, Mennone A, Soroka CJ, Boyer JL. J Pharmacol Exp Ther. 2014 Apr; 2014 Feb 3. PMID: 24492652.
- Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretion.Ghonem NS, Ananthanarayanan M, Soroka CJ, Boyer JL. Hepatology. 2014 Mar; 2014 Jan 27. PMID: 24122873.
- Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.Weerachayaphorn J, Luo Y, Mennone A, Soroka CJ, Harry K, Boyer JL. J Hepatol. 2014 Jan; 2013 Aug 23. PMID: 23978715.
- Adult sea lamprey tolerates biliary atresia by altering bile salt composition and renal excretion.Cai SY, Lionarons DA, Hagey L, Soroka CJ, Mennone A, Boyer JL. Hepatology. 2013 Jun. PMID: 23175353.
- Identification of functionally distinct Na-HCO3 co-transporters in colon.Barmeyer C, Ye JH, Soroka C, Geibel P, Hingsammer LM, Weitgasser L, Atway D, Geibel JP, Binder HJ, Rajendran VM. PLoS One. 2013; 2013 May 14. PMID: 23690961.
- A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis.Lam P, Xu S, Soroka CJ, Boyer JL. Hepatology. 2012 Jun; 2012 Apr 25. PMID: 22161577.
- Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.Weerachayaphorn J, Mennone A, Soroka CJ, Harry K, Hagey LR, Kensler TW, Boyer JL. Am J Physiol Gastrointest Liver Physiol. 2012 May 1; 2012 Feb 16. PMID: 22345550.
- Ostα depletion protects liver from oral bile acid load.Soroka CJ, Velazquez H, Mennone A, Ballatori N, Boyer JL. Am J Physiol Gastrointest Liver Physiol. 2011 Sep; 2011 Jun 30. PMID: 21719738.
- Role of breast cancer resistance protein in the adaptive response to cholestasis.Mennone A, Soroka CJ, Harry KM, Boyer JL. Drug Metab Dispos. 2010 Oct; 2010 Jul 2. PMID: 20601550.
- Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.Xu S, Weerachayaphorn J, Cai SY, Soroka CJ, Boyer JL. Am J Physiol Gastrointest Liver Physiol. 2010 Jul; 2010 Apr 15. PMID: 20395535.
- NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function.Li M, Wang W, Soroka CJ, Mennone A, Harry K, Weinman EJ, Boyer JL. J Biol Chem. 2010 Jun 18; 2010 Apr 19. PMID: 20404332.
- Organic solute transporter, OSTalpha-OSTbeta: its role in bile acid transport and cholestasis.Soroka CJ, Ballatori N, Boyer JL. Semin Liver Dis. 2010 May; 2010 Apr 26. PMID: 20422499.
- The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.Lam P, Soroka CJ, Boyer JL. Semin Liver Dis. 2010 May; 2010 Apr 26. PMID: 20422495.
- Mouse organic solute transporter alpha deficiency enhances renal excretion of bile acids and attenuates cholestasis.Soroka CJ, Mennone A, Hagey LR, Ballatori N, Boyer JL. Hepatology. 2010 Jan. PMID: 19902485.
- Nuclear factor erythroid 2-related factor 2 is a positive regulator of human bile salt export pump expression.Weerachayaphorn J, Cai SY, Soroka CJ, Boyer JL. Hepatology. 2009 Nov. PMID: 19821532.
- ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained.Cai SY, Gautam S, Nguyen T, Soroka CJ, Rahner C, Boyer JL. Gastroenterology. 2009 Mar; 2008 Nov 1. PMID: 19027009.
- Degradation of the bile salt export pump at endoplasmic reticulum in progressive familial intrahepatic cholestasis type II.Wang L, Dong H, Soroka CJ, Wei N, Boyer JL, Hochstrasser M. Hepatology. 2008 Nov. PMID: 18798335.
- N-Glycosylation of the alpha subunit does not influence trafficking or functional activity of the human organic solute transporter alpha/beta.Soroka CJ, Xu S, Mennone A, Lam P, Boyer JL. BMC Cell Biol. 2008 Oct 10; 2008 Oct 10. PMID: 18847488.
- Levels of plasma membrane expression in progressive and benign mutations of the bile salt export pump (Bsep/Abcb11) correlate with severity of cholestatic diseases.Lam P, Pearson CL, Soroka CJ, Xu S, Mennone A, Boyer JL. Am J Physiol Cell Physiol. 2007 Nov; 2007 Sep 13. PMID: 17855769.
- Nuclear receptors RXRalpha:RARalpha are repressors for human MRP3 expression.Chen W, Cai SY, Xu S, Denson LA, Soroka CJ, Boyer JL. Am J Physiol Gastrointest Liver Physiol. 2007 May; 2007 Feb 1. PMID: 17272513.
- Radixin is required to maintain apical canalicular membrane structure and function in rat hepatocytes.Wang W, Soroka CJ, Mennone A, Rahner C, Harry K, Pypaert M, Boyer JL. Gastroenterology. 2006 Sep. PMID: 16952556.
- Upregulation of a basolateral FXR-dependent bile acid efflux transporter OSTalpha-OSTbeta in cholestasis in humans and rodents.Boyer JL, Trauner M, Mennone A, Soroka CJ, Cai SY, Moustafa T, Zollner G, Lee JY, Ballatori N. Am J Physiol Gastrointest Liver Physiol. 2006 Jun; 2006 Jan 19. PMID: 16423920.
- Mrp4-/- mice have an impaired cytoprotective response in obstructive cholestasis.Mennone A, Soroka CJ, Cai SY, Harry K, Adachi M, Hagey L, Schuetz JD, Boyer JL. Hepatology. 2006 May. PMID: 16628672.
- A comparison of gene expression in mouse liver and kidney in obstructive cholestasis utilizing high-density oligonucleotide microarray technology.Denk GU, Cai SY, Chen WS, Lin A, Soroka CJ, Boyer JL. World J Gastroenterol. 2006 Apr 28. PMID: 16688799.
- Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis.Denk GU, Soroka CJ, Mennone A, Koepsell H, Beuers U, Boyer JL. Hepatology. 2004 May. PMID: 15122767.
- Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat.Denk GU, Soroka CJ, Takeyama Y, Chen WS, Schuetz JD, Boyer JL. J Hepatol. 2004 Apr. PMID: 15030973.
- Molecular characterization of a multidrug resistance-associated protein, Mrp2, from the little skate.Cai SY, Soroka CJ, Ballatori N, Boyer JL. Am J Physiol Regul Integr Comp Physiol. 2003 Jan; 2002 Oct 3. PMID: 12388433.
- The role of bile salt export pump mutations in progressive familial intrahepatic cholestasis type II.Wang L, Soroka CJ, Boyer JL. J Clin Invest. 2002 Oct. PMID: 12370274.
- Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes.Azzaroli F, Mehal W, Soroka CJ, Wang L, Lee J, Crispe IN, Boyer JL. Hepatology. 2002 Jul. PMID: 12085348.
- An evolutionarily ancient Oatp: insights into conserved functional domains of these proteins.Cai SY, Wang W, Soroka CJ, Ballatori N, Boyer JL. Am J Physiol Gastrointest Liver Physiol. 2002 Apr. PMID: 11897630.
Carlo Spirli, PhD
Mario Strazzabosco, MD, PhD
- Comparison of prognostic accuracy of HCC staging systems in patients undergoing TACE.Kasolowsky V, Gross M, Madoff DC, Duncan J, Taddei T, Strazzabosco M, Jaffe A, Chapiro J. Clin Imaging. 2025 Apr; 2025 Feb 25. PMID: 40049074.
- Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities.Gupta V, Sehrawat TS, Pinzani M, Strazzabosco M. Gastroenterology. 2025 Apr; 2024 Sep 7. PMID: 39251168.
- Second-Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta-Analysis.Giannini EG, Pasta A, Calabrese F, Labanca S, Marenco S, Pieri G, Plaz Torres MC, Strazzabosco M. Liver Int. 2025 Jan. PMID: 39720853.
- Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making.Sobirey R, Matuschewski N, Gross M, Lin M, Kao T, Kasolowsky V, Strazzabosco M, Stein S, Savic LJ, Gebauer B, Jaffe A, Duncan J, Madoff DC, Chapiro J. Eur Radiol. 2025 Jan; 2024 Jul 20. PMID: 39033181.
- Procoagulant phenotype of virus-infected pericytes is associated with portal thrombosis and intrapulmonary vascular dilations in fatal COVID-19.Cadamuro M, Lasagni A, Radu CM, Calistri A, Pilan M, Valle C, Bonaffini PA, Vitiello A, Toffanin S, Venturin C, Friòn-Herrera Y, Sironi S, Alessio MG, Previtali G, Seghezzi M, Gianatti A, Strazzabosco M, Strain AJ, Campello E, Spiezia L, Palù G, Frigo AC, Tosoni A, Nebuloni M, Parolin C, Sonzogni A, Simioni P, Fabris L. J Hepatol. 2024 Nov; 2024 Jun 20. PMID: 38908437.
- Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning.Gross M, Haider SP, Ze'evi T, Huber S, Arora S, Kucukkaya AS, Iseke S, Gebauer B, Fleckenstein F, Dewey M, Jaffe A, Strazzabosco M, Chapiro J, Onofrey JA. Eur Radiol. 2024 Oct; 2024 Mar 27. PMID: 38536464.
- Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.Bertolini A, Nguyen M, Zehra SA, Taleb SA, Bauer-Pisani T, Palm N, Strazzabosco M, Fiorotto R. J Hepatol. 2024 Sep; 2024 Mar 28. PMID: 38554847.
- Automated MRI liver segmentation for anatomical segmentation, liver volumetry, and the extraction of radiomics.Gross M, Huber S, Arora S, Ze'evi T, Haider SP, Kucukkaya AS, Iseke S, Kuhn TN, Gebauer B, Michallek F, Dewey M, Vilgrain V, Sartoris R, Ronot M, Jaffe A, Strazzabosco M, Chapiro J, Onofrey JA. Eur Radiol. 2024 Aug; 2024 Jan 13. PMID: 38217704.
- Cost-effectiveness analysis: The missing factor in the management of HCC.Njei B, Yi I, Strazzabosco M. Clin Liver Dis (Hoboken). 2024 Jan-Jun; 2024 Jun 7. PMID: 38860130.
- Safety and Efficacy of Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma and Impaired Liver Function: A Systematic Review and Meta-Analysis.Pasta A, Calabrese F, Jaffe A, Labanca S, Marenco S, Pieri G, Plaz Torres MC, Strazzabosco M, Giannini EG. Liver Cancer. 2024 Jun; 2023 Oct 14. PMID: 38756146.
- Approach to immunotherapy for HCC in the liver transplant population.Block PD, Strazzabosco M, Jaffe A. Clin Liver Dis (Hoboken). 2024 Jan-Jun; 2024 May 3. PMID: 38707244.
- It could happen in your backyard.Strazzabosco M. Hepatology. 2024 Apr 1; 2023 Sep 18. PMID: 37722133.
- Community-Level Factors Associated with Hepatocellular Carcinoma Incidence and Mortality: An Observational Registry Study.Mezzacappa C, Rossi R, Jaffe A, Taddei TH, Strazzabosco M. Cancer Epidemiol Biomarkers Prev. 2024 Feb 6. PMID: 38059831.
- May we actually help clinicians select the best systemic treatment for patients with intermediate-stage hepatocellular carcinoma?Giannini EG, Strazzabosco M. Liver Int. 2024 Feb. PMID: 38289589.
- European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care.Carbone M, Neuberger J, Rowe I, Polak WG, Forsberg A, Fondevila C, Mantovani L, Nardi A, Colli A, Rockell K, Schick L, Cristoferi L, Oniscu GC, Strazzabosco M, Cillo U. Transpl Int. 2023; 2024 Jan 25. PMID: 38332850.
- Reply: Novel antidiabetic drugs and the risk for HCC. What else to expect from these "wonderful" drug classes?Plaz Torres MC, Jaffe A, Perry R, Marabotto E, Strazzabosco M, Giannini EG. Hepatology. 2023 Jun 1; 2023 Feb 3. PMID: 36724446.
- Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma.Cao Y, Mezzacappa C, Jaffe A, Strazzabosco M, Taddei TH. J Multidiscip Healthc. 2023; 2023 May 31. PMID: 37283950.
- Cell-matrix interactions control biliary organoid polarity, architecture, and differentiation.Fiorotto R, Mariotti V, Taleb SA, Zehra SA, Nguyen M, Amenduni M, Strazzabosco M. Hepatol Commun. 2023 Apr 1; 2023 Mar 24. PMID: 36972396.
- Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma.Cadamuro M, Sarcognato S, Camerotto R, Girardi N, Lasagni A, Zanus G, Cillo U, Gringeri E, Morana G, Strazzabosco M, Campello E, Simioni P, Guido M, Fabris L. Int J Mol Sci. 2023 Mar 1; 2023 Mar 1. PMID: 36902188.
- Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC.Jaffe A, Taddei TH, Giannini EG, Ilagan-Ying YC, Colombo M, Strazzabosco M. Liver Int. 2023 Jan; 2022 Dec 5. PMID: 36426717.
- Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis.Kayali S, Pasta A, Plaz Torres MC, Jaffe A, Strazzabosco M, Marenco S, Giannini EG. Liver Int. 2023 Jan; 2022 Sep 27. PMID: 36102312.
- Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?Wang Y, Strazzabosco M, Madoff DC. Curr Oncol Rep. 2022 Dec; 2022 Oct 18. PMID: 36255606.
- Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook.Jaffe A, Taddei TH, Giannini EG, Ilagan-Ying YC, Colombo M, Strazzabosco M. Liver Int. 2022 Dec; 2022 Oct 11. PMID: 36161463.
- ESOT Consensus Platform for Organ Transplantation: Setting the Stage for a Rigorous, Regularly Updated Development Process.Cillo U, Weissenbacher A, Pengel L, Jochmans I, Roppolo D, Amarelli C, Belli LS, Berenguer M, De Vries A, Ferrer J, Friedewald J, Furian L, Greenwood S, Monbaliu D, Nadalin S, Neyrinck A, Strazzabosco M, Toso C, Zaza G, Thuraisingham R, Berney T, Potena L, Montserrat N, Selzner N. Transpl Int. 2022; 2022 Oct 24. PMID: 36406781.
- Bile acids and their receptors: modulators and therapeutic targets in liver inflammation.Bertolini A, Fiorotto R, Strazzabosco M. Semin Immunopathol. 2022 Jul; 2022 Apr 12. PMID: 35415765.
- Optimization of the BCLC Staging System for Locoregional Therapy for Hepatocellular Carcinoma by Using Quantitative Tumor Burden Imaging Biomarkers at MRI.Borde T, Nezami N, Laage Gaupp F, Savic LJ, Taddei T, Jaffe A, Strazzabosco M, Lin M, Duran R, Georgiades C, Hong K, Chapiro J. Radiology. 2022 Jul; 2022 Apr 12. PMID: 35412368.
- Translational Value of Tumor-Associated Lymphangiogenesis in Cholangiocarcinoma.Cadamuro M, Romanzi A, Guido M, Sarcognato S, Cillo U, Gringeri E, Zanus G, Strazzabosco M, Simioni P, Villa E, Fabris L. J Pers Med. 2022 Jun 30; 2022 Jun 30. PMID: 35887583.
- Dysregulation of the Scribble/YAP/β-catenin axis sustains the fibroinflammatory response in a PKHD1(-/-) mouse model of congenital hepatic fibrosis.Fabris L, Milani C, Fiorotto R, Mariotti V, Kaffe E, Seller B, Sonzogni A, Strazzabosco M, Cadamuro M. FASEB J. 2022 Jun. PMID: 35593740.
- Adjusting Barcelona Clinic Liver Cancer Staging System to the Evolving Landscape of Hepatocellular Carcinoma: A Look to the Future.Strazzabosco M, Cabibbo G, Colombo M. Gastroenterology. 2022 Jun; 2022 Feb 2. PMID: 35122767.
- The Neglected Role of Bile Duct Epithelial Cells in NASH.Cadamuro M, Lasagni A, Sarcognato S, Guido M, Fabris R, Strazzabosco M, Strain AJ, Simioni P, Villa E, Fabris L. Semin Liver Dis. 2022 Feb; 2021 Nov 18. PMID: 34794182.
- Tumor microenvironment and immunology of cholangiocarcinoma.Cadamuro M, Fabris L, Zhang X, Strazzabosco M. Hepatoma Res. 2022; 2022 Mar 10. PMID: 39301518.
- Inflammatory pathways and cholangiocarcinoma risk mechanisms and prevention.Cadamuro M, Strazzabosco M. Adv Cancer Res. 2022; 2022 Mar 10. PMID: 35961707.
- Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging.Gross M, Spektor M, Jaffe A, Kucukkaya AS, Iseke S, Haider SP, Strazzabosco M, Chapiro J, Onofrey JA. PLoS One. 2021; 2021 Dec 1. PMID: 34852007.
- Pathological characteristics of liver sinusoidal thrombosis in COVID-19 patients: A series of 43 cases.Kondo R, Kawaguchi N, McConnell MJ, Sonzogni A, Licini L, Valle C, Bonaffini PA, Sironi S, Alessio MG, Previtali G, Seghezzi M, Zhang X, Sun Z, Utsumi T, Strazzabosco M, Iwakiri Y. Hepatol Res. 2021 Sep; 2021 Aug 2. PMID: 34260803.
- Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy.McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, Bonaffini PA, Sironi S, Alessio MG, Previtali G, Seghezzi M, Zhang X, Lee AI, Pine AB, Chun HJ, Zhang X, Fernandez-Hernando C, Qing H, Wang A, Price C, Sun Z, Utsumi T, Hwa J, Strazzabosco M, Iwakiri Y. J Hepatol. 2021 Sep; 2021 May 13. PMID: 33991637.
- Thermal ablation alone vs thermal ablation combined with transarterial chemoembolization for patients with small (<3 cm) hepatocellular carcinoma.Chai NX, Chapiro J, Petukhova A, Gross M, Kucukkaya A, Raju R, Zeevi T, Elbanan M, Lin M, Perez-Lozada JC, Schlachter T, Strazzabosco M, Pollak JS, Madoff DC. Clin Imaging. 2021 Aug; 2021 Feb 11. PMID: 33592550.
- New insights on the role of vascular endothelial growth factor in biliary pathophysiology.Mariotti V, Fiorotto R, Cadamuro M, Fabris L, Strazzabosco M. JHEP Rep. 2021 Jun; 2021 Feb 4. PMID: 34151244.
- Reliable prediction of survival in advanced-stage hepatocellular carcinoma treated with sorafenib: comparing 1D and 3D quantitative tumor response criteria on MRI.Doemel LA, Chapiro J, Laage Gaupp F, Savic LJ, Kucukkaya AS, Petukhova A, Tefera J, Zeevi T, Lin M, Schlachter T, Jaffe A, Strazzabosco M, Patel T, Stein SM. Eur Radiol. 2021 May; 2020 Oct 30. PMID: 33123796.
- Fibrocystic liver disease: novel concepts and translational perspectives.Lasagni A, Cadamuro M, Morana G, Fabris L, Strazzabosco M. Transl Gastroenterol Hepatol. 2021; 2021 Apr 5. PMID: 33824930.
- Rare and undiagnosed liver diseases: challenges and opportunities.Fabris L, Strazzabosco M. Transl Gastroenterol Hepatol. 2021; 2021 Apr 5. PMID: 33824922.
- Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic.Cadamuro M, Lasagni A, Lamarca A, Fouassier L, Guido M, Sarcognato S, Gringeri E, Cillo U, Strazzabosco M, Marin JJ, Banales JM, Fabris L. Expert Opin Investig Drugs. 2021 Apr; 2021 Feb 23. PMID: 33622120.
- IL-17A/F enable cholangiocytes to restrict T cell-driven experimental cholangitis by upregulating PD-L1 expression.Stein S, Henze L, Poch T, Carambia A, Krech T, Preti M, Schuran FA, Reich M, Keitel V, Fiorotto R, Strazzabosco M, Fischer L, Li J, Müller LM, Wagner J, Gagliani N, Herkel J, Schwinge D, Schramm C. J Hepatol. 2021 Apr; 2020 Nov 13. PMID: 33197512.
- Intrahepatic cholangiocarcinoma: Morpho-molecular pathology, tumor reactive microenvironment, and malignant progression.Sirica AE, Strazzabosco M, Cadamuro M. Adv Cancer Res. 2021; 2020 Dec 9. PMID: 33579427.
- The Tumor Microenvironment in Cholangiocarcinoma Progression.Fabris L, Sato K, Alpini G, Strazzabosco M. Hepatology. 2021 Jan; 2020 Nov 6. PMID: 32500550.
- Health related quality of life in chronic liver diseases.Cortesi PA, Conti S, Scalone L, Jaffe A, Ciaccio A, Okolicsanyi S, Rota M, Fabris L, Colledan M, Fagiuoli S, Belli LS, Cesana G, Strazzabosco M, Mantovani LG. Liver Int. 2020 Nov. PMID: 32851764.
- Abnormal Liver Function Tests in Patients With COVID-19: Relevance and Potential Pathogenesis.Bertolini A, van de Peppel IP, Bodewes FAJA, Moshage H, Fantin A, Farinati F, Fiorotto R, Jonker JW, Strazzabosco M, Verkade HJ, Peserico G. Hepatology. 2020 Nov; 2020 Oct 20. PMID: 32702162.
- Value-based medicine, a compass to guide healthcare decisions in the COVID-19 aftermath.Strazzabosco M. Liver Int. 2020 Sep. PMID: 32677111.
- Cholangiocarcinoma 2020: the next horizon in mechanisms and management.Banales JM, Marin JJG, Lamarca A, Rodrigues PM, Khan SA, Roberts LR, Cardinale V, Carpino G, Andersen JB, Braconi C, Calvisi DF, Perugorria MJ, Fabris L, Boulter L, Macias RIR, Gaudio E, Alvaro D, Gradilone SA, Strazzabosco M, Marzioni M, Coulouarn C, Fouassier L, Raggi C, Invernizzi P, Mertens JC, Moncsek A, Ilyas SI, Heimbach J, Koerkamp BG, Bruix J, Forner A, Bridgewater J, Valle JW, Gores GJ. Nat Rev Gastroenterol Hepatol. 2020 Sep; 2020 Jun 30. PMID: 32606456.
- Liver Matrix in Benign and Malignant Biliary Tract Disease.Fabris L, Cadamuro M, Cagnin S, Strazzabosco M, Gores GJ. Semin Liver Dis. 2020 Aug; 2020 Mar 11. PMID: 32162285.
- Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?Plaz Torres MC, Bodini G, Furnari M, Marabotto E, Zentilin P, Strazzabosco M, Giannini EG. Cancers (Basel). 2020 May 31; 2020 May 31. PMID: 32486355.
- The Emerging Role of Macrophages in Chronic Cholangiopathies Featuring Biliary Fibrosis: An Attractive Therapeutic Target for Orphan Diseases.Cadamuro M, Girardi N, Gores GJ, Strazzabosco M, Fabris L. Front Med (Lausanne). 2020; 2020 Apr 21. PMID: 32373615.
- Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.Strazzabosco M, Cortesi PA, Conti S, Okolicsanyi S, Rota M, Ciaccio A, Cozzolino P, Fornari C, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Zavaglia C, Perricone G, Munari LM, Mantovani LG, Belli LS. Liver Int. 2020 Jan; 2019 Nov 12. PMID: 31654608.
- The challenges of primary biliary cholangitis: What is new and what needs to be done.Terziroli Beretta-Piccoli B, Mieli-Vergani G, Vergani D, Vierling JM, Adams D, Alpini G, Banales JM, Beuers U, Björnsson E, Bowlus C, Carbone M, Chazouillères O, Dalekos G, De Gottardi A, Harada K, Hirschfield G, Invernizzi P, Jones D, Krawitt E, Lanzavecchia A, Lian ZX, Ma X, Manns M, Mavilio D, Quigley EM, Sallusto F, Shimoda S, Strazzabosco M, Swain M, Tanaka A, Trauner M, Tsuneyama K, Zigmond E, Gershwin ME. J Autoimmun. 2019 Dec; 2019 Sep 20. PMID: 31548157.
- Modeling of implementation of the new Organ Procurement and Transplantation Network/United Network for Organ Sharing policy for patients with hepatocellular carcinoma.Kokabi N, Nezami N, Xing M, Ludwig JM, Strazzabosco M, Kim HS. J Comp Eff Res. 2019 Sep; 2019 Sep 12. PMID: 31512955.
- Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases.Fabris L, Fiorotto R, Spirli C, Cadamuro M, Mariotti V, Perugorria MJ, Banales JM, Strazzabosco M. Nat Rev Gastroenterol Hepatol. 2019 Aug. PMID: 31165788.
- The tumour microenvironment and immune milieu of cholangiocarcinoma.Fabris L, Perugorria MJ, Mertens J, Björkström NK, Cramer T, Lleo A, Solinas A, Sänger H, Lukacs-Kornek V, Moncsek A, Siebenhüner A, Strazzabosco M. Liver Int. 2019 May. PMID: 30907492.
- Cholangiocyte pathobiology.Banales JM, Huebert RC, Karlsen T, Strazzabosco M, LaRusso NF, Gores GJ. Nat Rev Gastroenterol Hepatol. 2019 May. PMID: 30850822.
- Animal models of cholestasis: An update on inflammatory cholangiopathies.Mariotti V, Cadamuro M, Spirli C, Fiorotto R, Strazzabosco M, Fabris L. Biochim Biophys Acta Mol Basis Dis. 2019 May 1; 2018 Aug 11. PMID: 30398152.
- Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Biochim Biophys Acta Mol Basis Dis. 2019 May 1; 2018 Sep 5. PMID: 30264693.
- Animal models for cystic fibrosis liver disease (CFLD).Fiorotto R, Amenduni M, Mariotti V, Cadamuro M, Fabris L, Spirli C, Strazzabosco M. Biochim Biophys Acta Mol Basis Dis. 2019 May 1; 2018 Jul 30. PMID: 30071276.
- Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.Cadamuro M, Brivio S, Mertens J, Vismara M, Moncsek A, Milani C, Fingas C, Cristina Malerba M, Nardo G, Dall'Olmo L, Milani E, Mariotti V, Stecca T, Massani M, Spirli C, Fiorotto R, Indraccolo S, Strazzabosco M, Fabris L. J Hepatol. 2019 Apr; 2018 Dec 14. PMID: 30553841.
- Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances.Sirica AE, Gores GJ, Groopman JD, Selaru FM, Strazzabosco M, Wei Wang X, Zhu AX. Hepatology. 2019 Apr; 2019 Mar 25. PMID: 30251463.
- Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.Fiorotto R, Strazzabosco M. Cell Mol Gastroenterol Hepatol. 2019; 2019 May 7. PMID: 31075352.
- Fibroinflammatory Liver Injuries as Preneoplastic Condition in Cholangiopathies.Cannito S, Milani C, Cappon A, Parola M, Strazzabosco M, Cadamuro M. Int J Mol Sci. 2018 Dec 4; 2018 Dec 4. PMID: 30518128.
- Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation.Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V, Strazzabosco M, Dalprà L, Lavitrano M, Bentivegna A. Genes (Basel). 2018 Oct 26; 2018 Oct 26. PMID: 30373123.
- Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.Belli LS, Perricone G, Adam R, Cortesi PA, Strazzabosco M, Facchetti R, Karam V, Salizzoni M, Andujar RL, Fondevila C, De Simone P, Morelli C, Fabregat-Prous J, Samuel D, Agarwaal K, Moreno Gonzales E, Charco R, Zieniewicz K, De Carlis L, Duvoux C. J Hepatol. 2018 Oct; 2018 Jun 27. PMID: 29940268.
- Animal models of cholangiocarcinoma: What they teach us about the human disease.Cadamuro M, Brivio S, Stecca T, Kaffe E, Mariotti V, Milani C, Fiorotto R, Spirli C, Strazzabosco M, Fabris L. Clin Res Hepatol Gastroenterol. 2018 Oct; 2018 May 9. PMID: 29753731.
- Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions.Ippolito D, Querques G, Okolicsanyi S, Talei Franzesi C, Pecorelli A, Lombardi S, Orsini E, Strazzabosco M, Sironi S. Eur J Radiol. 2018 Sep; 2018 Jul 20. PMID: 30150052.
- The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities.Cortesi PA, Belli LS, Facchetti R, Mazzarelli C, Perricone G, De Nicola S, Cesana G, Duvoux C, Mantovani LG, Strazzabosco M. J Viral Hepat. 2018 Jul; 2018 Mar 8. PMID: 29406608.
- β-Catenin and interleukin-1β-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis.Kaffe E, Fiorotto R, Pellegrino F, Mariotti V, Amenduni M, Cadamuro M, Fabris L, Strazzabosco M, Spirli C. Hepatology. 2018 May; 2018 Mar 25. PMID: 29140564.
- Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine.Carbone M, Cristoferi L, Cortesi PA, Rota M, Ciaccio A, Okolicsanyi S, Gemma M, Scalone L, Cesana G, Fabris L, Colledan M, Fagiuoli S, Ideo G, Belli LS, Munari LM, Mantovani L, Strazzabosco M. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 2017 Aug 24. PMID: 28844954.
- The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma.Cadamuro M, Stecca T, Brivio S, Mariotti V, Fiorotto R, Spirli C, Strazzabosco M, Fabris L. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 2017 Jul 27. PMID: 28757170.
- Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium.Strazzabosco M, Fiorotto R, Cadamuro M, Spirli C, Mariotti V, Kaffe E, Scirpo R, Fabris L. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 2017 Jul 25. PMID: 28754453.
- Animal models of biliary injury and altered bile acid metabolism.Mariotti V, Strazzabosco M, Fabris L, Calvisi DF. Biochim Biophys Acta Mol Basis Dis. 2018 Apr; 2017 Jul 11. PMID: 28709963.
- Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.Fiorotto R, Amenduni M, Mariotti V, Fabris L, Spirli C, Strazzabosco M. Hepatology. 2018 Mar; 2018 Jan 26. PMID: 28836688.
- Notch signaling and progenitor/ductular reaction in steatohepatitis.Morell CM, Fiorotto R, Meroni M, Raizner A, Torsello B, Cadamuro M, Spagnuolo G, Kaffe E, Sutti S, Albano E, Strazzabosco M. PLoS One. 2017; 2017 Nov 15. PMID: 29140985.
- ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.Belli LS, Duvoux C, Berenguer M, Berg T, Coilly A, Colle I, Fagiuoli S, Khoo S, Pageaux GP, Puoti M, Samuel D, Strazzabosco M. J Hepatol. 2017 Sep; 2017 Mar 18. PMID: 28323126.
- Emerging concepts in biliary repair and fibrosis.Fabris L, Spirli C, Cadamuro M, Fiorotto R, Strazzabosco M. Am J Physiol Gastrointest Liver Physiol. 2017 Aug 1; 2017 May 19. PMID: 28526690.
- Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis.Ciaccio A, Cortesi PA, Bellelli G, Rota M, Conti S, Okolicsanyi S, Rota M, Cesana G, Mantovani LG, Annoni G, Strazzabosco M. Liver Int. 2017 Jul; 2017 Mar 2. PMID: 27943549.
- Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study.Ippolito D, Querques G, Okolicsanyi S, Franzesi CT, Strazzabosco M, Sironi S. Eur J Radiol. 2017 May; 2017 Feb 20. PMID: 28583645.
- Value-based care in hepatology.Strazzabosco M, Allen JI, Teisberg EO. Hepatology. 2017 May. PMID: 28073146.
- Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.Spirli C, Mariotti V, Villani A, Fabris L, Fiorotto R, Strazzabosco M. J Hepatol. 2017 Mar; 2016 Nov 5. PMID: 27826057.
- Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Cadamuro M, Brivio S, Spirli C, Joplin RE, Strazzabosco M, Fabris L. Int J Mol Sci. 2017 Jan 13; 2017 Jan 13. PMID: 28098760.
- Liver-allocation policies for patients affected by HCC in Europe.De Carlis L, Di Sandro S, Centonze L, Lauterio A, Buscemi V, De Carlis R, Ferla F, Sguinzi R, Okolicsanyi S, Belli L, Strazzabosco M. Curr Transplant Rep. 2016 Dec; 2016 Oct 7. PMID: 28473952.
- The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.Fiorotto R, Villani A, Kourtidis A, Scirpo R, Amenduni M, Geibel PJ, Cadamuro M, Spirli C, Anastasiadis PZ, Strazzabosco M. Hepatology. 2016 Dec; 2016 Oct 27. PMID: 27629435.
- Cystic Fibrosis-Related Liver Diseases: New Paradigm for Treatment Based on Pathophysiology.Fiorotto R, Strazzabosco M. Clin Liver Dis (Hoboken). 2016 Nov; 2016 Nov 30. PMID: 31041076.
- Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases.Mantovani LG, Cortesi PA, Strazzabosco M. Hepatology. 2016 Oct; 2016 Apr 4. PMID: 26926906.
- Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study.Belli LS, Berenguer M, Cortesi PA, Strazzabosco M, Rockenschaub SR, Martini S, Morelli C, Donato F, Volpes R, Pageaux GP, Coilly A, Fagiuoli S, Amaddeo G, Perricone G, Vinaixa C, Berlakovich G, Facchetti R, Polak W, Muiesan P, Duvoux C. J Hepatol. 2016 Sep; 2016 May 17. PMID: 27212241.
- Low-Dose Paclitaxel Reduces S100A4 Nuclear Import to Inhibit Invasion and Hematogenous Metastasis of Cholangiocarcinoma.Cadamuro M, Spagnuolo G, Sambado L, Indraccolo S, Nardo G, Rosato A, Brivio S, Caslini C, Stecca T, Massani M, Bassi N, Novelli E, Spirli C, Fabris L, Strazzabosco M. Cancer Res. 2016 Aug 15; 2016 Jun 21. PMID: 27328733.
- Macrophage recruitment by fibrocystin-defective biliary epithelial cells promotes portal fibrosis in congenital hepatic fibrosis.Locatelli L, Cadamuro M, Spirlì C, Fiorotto R, Lecchi S, Morell CM, Popov Y, Scirpo R, De Matteis M, Amenduni M, Pietrobattista A, Torre G, Schuppan D, Fabris L, Strazzabosco M. Hepatology. 2016 Mar; 2016 Jan 16. PMID: 26645994.
- Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "Reactive" Biliary Epithelial Phenotype.Fabris L, Brivio S, Cadamuro M, Strazzabosco M. Stem Cells Int. 2016; 2016 Jan 6. PMID: 26880950.
- Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?Brivio S, Cadamuro M, Fabris L, Strazzabosco M. J Clin Med. 2015 Dec 19; 2015 Dec 19. PMID: 26703747.
- Posttranslational regulation of polycystin-2 protein expression as a novel mechanism of cholangiocyte reaction and repair from biliary damage.Spirli C, Villani A, Mariotti V, Fabris L, Fiorotto R, Strazzabosco M. Hepatology. 2015 Dec; 2015 Oct 10. PMID: 26313562.
- Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium.Scirpo R, Fiorotto R, Villani A, Amenduni M, Spirli C, Strazzabosco M. Hepatology. 2015 Nov; 2015 Aug 28. PMID: 26199136.
- Leukemia inhibitory factor protects cholangiocarcinoma cells from drug-induced apoptosis via a PI3K/AKT-dependent Mcl-1 activation.Morton SD, Cadamuro M, Brivio S, Vismara M, Stecca T, Massani M, Bassi N, Furlanetto A, Joplin RE, Floreani A, Fabris L, Strazzabosco M. Oncotarget. 2015 Sep 22. PMID: 26296968.
- Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort.Belli LS, Romagnoli R, Nardi A, Marianelli T, Donato F, Corradini SG, Iemmolo RM, Morelli C, Pasulo L, Rendina M, De Martin E, Ponziani FR, Volpes R, Strazzabosco M, Angelico M. Dig Liver Dis. 2015 Aug; 2015 Apr 16. PMID: 26055490.
- Cost-Effectiveness of New Direct-Acting Antivirals to Prevent Post-Liver Transplant Recurrent Hepatitis.Cortesi PA, Mantovani LG, Ciaccio A, Rota M, Mazzarelli C, Cesana G, Strazzabosco M, Belli LS. Am J Transplant. 2015 Jul. PMID: 26086300.
- Osteopontin: a new player in regulating hepatic ductular reaction and hepatic progenitor cell responses during chronic liver injury.Strazzabosco M, Fabris L, Albano E. Gut. 2014 Nov; 2014 Jul 23. PMID: 25056656.
- Neural cell adhesion molecule and polysialic acid in ductular reaction: the puzzle is far from completed, but the picture is becoming more clear.Strazzabosco M, Fabris L. Hepatology. 2014 Nov; 2014 Oct 1. PMID: 24995463.
- Characterization of animal models for primary sclerosing cholangitis (PSC).Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M. J Hepatol. 2014 Jun; 2014 Feb 19. PMID: 24560657.
Tamar Hamosh Taddei, MD
- AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension.Sterling RK, Asrani SK, Levine D, Duarte-Rojo A, Patel K, Fiel MI, Leung DH, Taouli B, Alsawas M, Murad MH, Dranoff JA, Taddei TH, Rockey DC. Hepatology. 2025 Mar 1; 2024 Mar 15. PMID: 38489663.
- Critical Update: AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.Taddei TH, Brown DB, Yarchoan M, Mendiratta-Lala M, Llovet JM. Hepatology. 2025 Feb 24; 2025 Feb 24. PMID: 39992051.
- Mortality, Hepatic Decompensation, and Cardiovascular Outcomes in Lean vs. Non-lean MASLD Cirrhosis: A Veterans Affairs Cohort Study.Njei B, Mezzacappa C, John BV, Serper M, Kaplan DE, Taddei TH, Mahmud N. Dig Dis Sci. 2025 Feb; 2025 Jan 8. PMID: 39779587.
- AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis.Sterling RK, Duarte-Rojo A, Patel K, Asrani SK, Alsawas M, Dranoff JA, Fiel MI, Murad MH, Leung DH, Levine D, Taddei TH, Taouli B, Rockey DC. Hepatology. 2025 Feb 1; 2024 Mar 15. PMID: 38489518.
- Clinical outcomes and care for spontaneous bacterial peritonitis: A national cohort study.Serper M, Tang H, Zhang S, McCullough A, Kaplan DE, Taddei TH, Mahmud N. Hepatology. 2025 Jan 29; 2025 Jan 29. PMID: 39879583.
- Identifying Metabolic Dysfunction-Associated Steatotic Liver Disease Using Natural Language Processing in a US National Cohort.John BV, Bastaich D, Mezzacappa C, Ferreira RD, Hentschel A, Samos A, Mahmud N, Taddei TH, Kaplan D, Serper M, Dahman B. Am J Gastroenterol. 2025 Jan 16; 2025 Jan 16. PMID: 39950372.
- AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis.Sterling RK, Patel K, Duarte-Rojo A, Asrani SK, Alsawas M, Dranoff JA, Fiel MI, Murad MH, Leung DH, Levine D, Taddei TH, Taouli B, Rockey DC. Hepatology. 2025 Jan 1; 2024 Mar 15. PMID: 38489523.
- Accuracy of blood-based biomarkers for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline.Patel K, Asrani SK, Fiel MI, Levine D, Leung DH, Duarte-Rojo A, Dranoff JA, Nayfeh T, Hasan B, Taddei TH, Alsawaf Y, Saadi S, Majzoub AM, Manolopoulos A, Alzuabi M, Ding J, Sofiyeva N, Murad MH, Alsawas M, Rockey DC, Sterling RK. Hepatology. 2025 Jan 1; 2024 Mar 15. PMID: 38489517.
- Validation and expansion of Baveno VII criteria for cACLD and CSPH based on liver stiffness and platelet count: Correlation with risk of hepatic decompensation and death.Vutien P, Barnard Giustini A, Kim NJ, Moon AM, Hsu CN, Mezzacappa C, Borgerding JA, Johnson KM, VoPham T, Berry K, Beste LA, Kaplan DE, Taddei TH, Ioannou GN. Hepatology. 2024 Dec 17; 2024 Dec 17. PMID: 39689352.
- Validation and Epidemiologic Definition of the Novel Steatotic Liver Disease Nomenclature in a National United States Cohort With Cirrhosis.Mezzacappa C, Ochoa-Allemant P, Serper M, Taddei TH, John BV, Kaplan DE, Mahmud N. Clin Gastroenterol Hepatol. 2024 Dec 15; 2024 Dec 15. PMID: 39689774.
- Hepatotoxicity Score: A New Method to Adjust for Use of Potentially Hepatotoxic Medications by Chronic Liver Disease Status.Lo Re V 3rd, Newcomb CW, Carbonari DM, Mezochow AK, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Torgersen J. Pharmacoepidemiol Drug Saf. 2024 Dec. PMID: 39662972.
- Albumin for Spontaneous Bacterial Peritonitis: Care Variation, Disparities, and Outcomes.Serper M, Pulaski ME, Zhang S, Taddei TH, Kaplan DE, Mahmud N. Am J Gastroenterol. 2024 Nov 12; 2024 Nov 12. PMID: 39530516.
- Risk Score for Hepatocellular Cancer in Adults Without Viral Hepatitis or Cirrhosis.Ilagan-Ying YC, Gordon KS, Tate JP, Lim JK, Torgersen J, Lo Re V 3rd, Justice AC, Taddei TH. JAMA Netw Open. 2024 Nov 4; 2024 Nov 4. PMID: 39504020.
- A Validated Algorithm to Identify Hepatic Decompensation in the Veterans Health Administration Electronic Health Record System.Haque LY, Tate JP, Chew M, Caniglia EC, Taddei TH, Re VL 3rd. Pharmacoepidemiol Drug Saf. 2024 Nov. PMID: 39477692.
- Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data.Torgersen J, Mezochow AK, Newcomb CW, Carbonari DM, Hennessy S, Rentsch CT, Park LS, Tate JP, Bräu N, Bhattacharya D, Lim JK, Mezzacappa C, Njei B, Roy JA, Taddei TH, Justice AC, Lo Re V 3rd. JAMA Intern Med. 2024 Aug 1. PMID: 38913369.
- Screening for Hepatocellular Carcinoma and Survival in Patients With Cirrhosis After Hepatitis C Virus Cure.Mezzacappa C, Kim NJ, Vutien P, Kaplan DE, Ioannou GN, Taddei TH. JAMA Netw Open. 2024 Jul 1; 2024 Jul 1. PMID: 38985470.
- Identification of hepatic steatosis among persons with and without HIV using natural language processing.Torgersen J, Skanderson M, Kidwai-Khan F, Carbonari DM, Tate JP, Park LS, Bhattacharya D, Lim JK, Taddei TH, Justice AC, Lo Re V 3rd. Hepatol Commun. 2024 Jul 1; 2024 Jun 19. PMID: 38896066.
- Organizational and Implementation Factors Associated with Cirrhosis Care in the Veterans Health Administration.McCurdy H, Nobbe A, Scott D, Patton H, Morgan TR, Bajaj JS, Yakovchenko V, Merante M, Gibson S, Lamorte C, Baffy G, Ioannou GN, Taddei TH, Rozenberg-Ben-Dror K, Anwar J, Dominitz JA, Rogal SS. Dig Dis Sci. 2024 Jun; 2024 Apr 14. PMID: 38616215.
- Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update.Gordan JD, Kennedy EB, Abou-Alfa GK, Beal E, Finn RS, Gade TP, Goff L, Gupta S, Guy J, Hoang HT, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Kortmansky J, Leaf A, Remak WM, Sohal DPS, Taddei TH, Wilson Woods A, Yarchoan M, Rose MG. J Clin Oncol. 2024 May 20; 2024 Mar 19. PMID: 38502889.
- Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.John BV, Dang Y, Kaplan DE, Jou JH, Taddei TH, Spector SA, Martin P, Bastaich DR, Chao HH, Dahman B. Clin Gastroenterol Hepatol. 2024 Apr; 2023 Dec 5. PMID: 38061410.
- Refractory hepatic hydrothorax is associated with increased mortality with death occurring at lower MELD-Na compared to cirrhosis and refractory ascites.Chin A, Bastaich DR, Dahman B, Kaplan DE, Taddei TH, John BV. Hepatology. 2024 Apr 1; 2023 Aug 25. PMID: 37625139.
- Deploying a national clinical text processing infrastructure.McManus KF, Stringer JM, Corson N, Fodeh S, Steinhardt S, Levin FL, Shotqara AS, D'Auria J, Fielstein EM, Gobbel GT, Scott J, Trafton JA, Taddei TH, Erdos J, Tamang SR. J Am Med Inform Assoc. 2024 Feb 16. PMID: 38146986.
- Community-Level Factors Associated with Hepatocellular Carcinoma Incidence and Mortality: An Observational Registry Study.Mezzacappa C, Rossi R, Jaffe A, Taddei TH, Strazzabosco M. Cancer Epidemiol Biomarkers Prev. 2024 Feb 6. PMID: 38059831.
- The Association Between Homelessness and Key Liver-Related Outcomes in Veterans With Cirrhosis.Pulaski M, Bittermann T, Taddei TH, Kaplan DE, Mahmud N. Am J Gastroenterol. 2024 Feb 1; 2023 Oct 27. PMID: 37782293.
- Hepatocellular Carcinoma Diagnosis and Management in 2021: A National Veterans Affairs Quality Improvement Project.Rogal SS, Taddei TH, Monto A, Yakovchenko V, Patton H, Merante M, Spoutz P, Chia L, Yudkevich J, Aytaman A, Rabiee A, John BV, Blechacz B, Cai CX, Gilles H, Shah AS, McCurdy H, Puri P, Jou J, Mazhar K, Dominitz JA, Anwar J, Morgan TR, Ioannou GN. Clin Gastroenterol Hepatol. 2024 Feb; 2023 Jul 15. PMID: 37460005.
- HCC is associated with diabetes and longitudinal blood glucose control in a national cohort with cirrhosis.Mezzacappa C, Mahmud N, Serper M, John BV, Taddei TH, Kaplan DE. Hepatol Commun. 2023 Dec 1; 2023 Dec 7. PMID: 38055642.
- AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.Singal AG, Llovet JM, Yarchoan M, Mehta N, Heimbach JK, Dawson LA, Jou JH, Kulik LM, Agopian VG, Marrero JA, Mendiratta-Lala M, Brown DB, Rilling WS, Goyal L, Wei AC, Taddei TH. Hepatology. 2023 Dec 1; 2023 May 22. PMID: 37199193.
- Performance of an automated deep learning algorithm to identify hepatic steatosis within noncontrast computed tomography scans among people with and without HIV.Torgersen J, Akers S, Huo Y, Terry JG, Carr JJ, Ruutiainen AT, Skanderson M, Levin W, Lim JK, Taddei TH, So-Armah K, Bhattacharya D, Rentsch CT, Shen L, Carr R, Shinohara RT, McClain M, Freiberg M, Justice AC, Lo Re V 3rd. Pharmacoepidemiol Drug Saf. 2023 Oct; 2023 Jun 8. PMID: 37276449.
- Multidisciplinary teams, efficient communication, procedure services, and telehealth improve cirrhosis care: A qualitative study.Serper M, Agha A, Garren PA, Taddei TH, Kaplan DE, Groeneveld PW, Werner RM, Shea JA. Hepatol Commun. 2023 Jun 1; 2023 May 23. PMID: 37219845.
- Using Telemedicine to Facilitate Patient Communication and Treatment Decision-Making Following Multidisciplinary Tumor Board Review for Patients with Hepatocellular Carcinoma.Choi DT, Sada YH, Sansgiry S, Kaplan DE, Taddei TH, Aguilar JK, Strayhorn M, Hernaez R, Davila JA. J Gastrointest Cancer. 2023 Jun; 2022 Jun 30. PMID: 35773376.
- Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma.Cao Y, Mezzacappa C, Jaffe A, Strazzabosco M, Taddei TH. J Multidiscip Healthc. 2023; 2023 May 31. PMID: 37283950.
- Ursodeoxycholic acid is associated with a reduction in SARS-CoV-2 infection and reduced severity of COVID-19 in patients with cirrhosis.John BV, Bastaich D, Webb G, Brevini T, Moon A, Ferreira RD, Chin AM, Kaplan DE, Taddei TH, Serper M, Mahmud N, Deng Y, Chao HH, Sampaziotis F, Dahman B. J Intern Med. 2023 May; 2023 Apr 5. PMID: 37018129.
- The association between mental illness and all-cause mortality in patients with cirrhosis: a Veterans Affairs retrospective cohort study.Shaffer LR, Kaplan DE, Taddei TH, Mahmud N. Hepatol Commun. 2023 Apr 1; 2023 Mar 30. PMID: 36996031.
- Enhanced Identification of Hispanic Ethnicity Using Clinical Data: A Study in the Largest Integrated United States Health Care System.Ochoa-Allemant P, Tate JP, Williams EC, Gordon KS, Marconi VC, Bensley KMK, Rentsch CT, Wang KH, Taddei TH, Justice AC. Med Care. 2023 Apr 1; 2023 Feb 3. PMID: 36893404.
- Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study.Mahmud N, Reddy KR, Taddei TH, Kaplan DE. Dig Dis Sci. 2023 Apr; 2022 Sep 9. PMID: 36083379.
- Attacking the public health crisis of hepatocellular carcinoma at its roots.Lee HM, Lidofsky SD, Taddei TH, Townshend-Bulson LJ. Hepatology. 2023 Apr 1; 2022 Oct 11. PMID: 35989555.
- When to Stop Screening-Liver Cancer.Taddei TH, Jou JH. Am J Gastroenterol. 2023 Mar 1; 2022 Dec 23. PMID: 36563304.
- "Am I Going to Die?": Delivering Serious News to Patients With Liver Disease.Patel AA, Arnold RM, Taddei TH, Woodrell CD. Gastroenterology. 2023 Feb; 2022 Nov 12. PMID: 36379246.
- Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic.Serper M, Tapper EB, Kaplan DE, Taddei TH, Mahmud N. Am J Gastroenterol. 2023 Feb 1; 2022 Sep 6. PMID: 36114778.
- Nonselective beta blockers, hepatic decompensation, and mortality in cirrhosis: A national cohort study.Serper M, Kaplan DE, Taddei TH, Tapper EB, Cohen JB, Mahmud N. Hepatology. 2023 Feb 1; 2022 Oct 17. PMID: 35984731.
- Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC.Jaffe A, Taddei TH, Giannini EG, Ilagan-Ying YC, Colombo M, Strazzabosco M. Liver Int. 2023 Jan; 2022 Dec 5. PMID: 36426717.
- Comparison of infection-induced and vaccine-induced immunity against COVID-19 in patients with cirrhosis.John BV, Doshi A, Ferreira RD, Taddei TH, Kaplan DE, Spector SA, Deng Y, Bastaich D, Dahman B. Hepatology. 2023 Jan 1; 2022 Jul 5. PMID: 35712794.
- Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook.Jaffe A, Taddei TH, Giannini EG, Ilagan-Ying YC, Colombo M, Strazzabosco M. Liver Int. 2022 Dec; 2022 Oct 11. PMID: 36161463.
- Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis.John BV, Ferreira RD, Doshi A, Kaplan DE, Taddei TH, Spector SA, Paulus E, Deng Y, Bastaich D, Dahman B. J Hepatol. 2022 Nov; 2022 Sep 28. PMID: 36181987.
- Effectiveness of COVID-19 Viral Vector Ad.26.COV2.S Vaccine and Comparison with mRNA Vaccines in Cirrhosis.John BV, Sidney Barritt A 4th, Moon A, Taddei TH, Kaplan DE, Dahman B, Doshi A, Deng Y, Mansour N, Ioannou G, Martin P, Chao HH. Clin Gastroenterol Hepatol. 2022 Oct; 2022 Jun 16. PMID: 35716904.
- Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study.Howell J, Samani A, Mannan B, Hajiev S, Motedayen Aval L, Abdelmalak R, Tam VC, Bettinger D, Thimme R, Taddei TH, Kaplan DE, Seidensticker M, Sharma R. Therap Adv Gastroenterol. 2022; 2022 Sep 30. PMID: 36199289.
- Cancer tracking system improves timeliness of liver cancer care at a Veterans Hospital: A comparison of cohorts before and after implementation of an automated care coordination tool.Zhang Y, Mezzacappa C, Shen L, Ivatorov A, Petukhova-Greenstein A, Mehta R, Ciarleglio M, Deng Y, Levin W, Steinhardt S, Connery D, Pineau M, Onyiuke I, Taylor C, Rose MG, Taddei TH. PLOS Digit Health. 2022 Aug; 2022 Aug 1. PMID: 36812575.
- The Association Between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients With Cirrhosis: A Veterans Affairs Cohort Study.Mahmud N, Serper M, Taddei TH, Kaplan DE. Gastroenterology. 2022 Jul; 2022 Apr 6. PMID: 35398042.
- Reply to: "Is it safe to treat chronic hepatitis C patients with decompensated cirrhosis with PI-based DAAs?".Torgersen J, Taddei TH, Lo Re V 3rd. J Hepatol. 2022 Jul; 2022 Mar 10. PMID: 35283213.
- Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis.John BV, Deng Y, Schwartz KB, Taddei TH, Kaplan DE, Martin P, Chao HH, Dahman B. Hepatology. 2022 Jul; 2022 Feb 22. PMID: 35023206.
- Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.Serper M, Kaplan DE, Lin M, Taddei TH, Parikh ND, Werner RM, Tapper EB. Dig Dis Sci. 2022 Jun; 2021 Aug 10. PMID: 34374917.
- Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort.Mahmud N, Chapin S, Goldberg DS, Reddy KR, Taddei TH, Kaplan DE. J Hepatol. 2022 May; 2022 Jan 21. PMID: 35066085.
- Risk Prediction Models for Postoperative Decompensation and Infection in Patients With Cirrhosis: A Veterans Affairs Cohort Study.Mahmud N, Fricker Z, Lewis JD, Taddei TH, Goldberg DS, Kaplan DE. Clin Gastroenterol Hepatol. 2022 May; 2021 Jul 8. PMID: 34246794.
- Palliative Care Always: Hepatology-Virtual Primary Palliative Care Training for Hepatologists.DeNofrio JC, Verma M, Kosinski AS, Navarro V, Taddei TH, Volk ML, Bakitas M, Ramchandran K. Hepatol Commun. 2022 Apr; 2021 Oct 31. PMID: 34719137.
- Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.Mahmud N, Asrani SK, Reese PP, Kaplan DE, Taddei TH, Nadim MK, Serper M. Dig Dis Sci. 2022 Apr; 2021 Mar 24. PMID: 33761091.
- Coronavirus Disease 2019 Vaccination Is Associated With Reduced Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Death in Liver Transplant Recipients.John BV, Deng Y, Khakoo NS, Taddei TH, Kaplan DE, Dahman B. Gastroenterology. 2022 Feb; 2021 Nov 7. PMID: 34758352.
- Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.John BV, Dahman B, Deng Y, Khakoo NS, Taddei TH, Kaplan DE, Levy C. Liver Int. 2022 Feb; 2021 Oct 12. PMID: 34614294.
- Oral Cyanobacteria and Hepatocellular Carcinoma.Hernandez BY, Zhu X, Risch HA, Lu L, Ma X, Irwin ML, Lim JK, Taddei TH, Pawlish KS, Stroup AM, Brown R, Wang Z, Wong LL, Yu H. Cancer Epidemiol Biomarkers Prev. 2022 Jan; 2021 Oct 25. PMID: 34697061.
- Evaluation Within 30 Days of Referral for Liver Transplantation is Associated with Reduced Mortality: A Multicenter Analysis of Patients Referred Within the VA Health System.John BV, Schwartz K, Scheinberg AR, Dahman B, Spector S, Deng Y, Goldberg D, Martin P, Taddei TH, Kaplan DE. Transplantation. 2022 Jan 1. PMID: 33587434.
- Protease inhibitor-based direct-acting antivirals are associated with increased risk of aminotransferase elevations but not hepatic dysfunction or decompensation.Torgersen J, Newcomb CW, Carbonari DM, Rentsch CT, Park LS, Mezochow A, Mehta RL, Buchwalder L, Tate JP, Bräu N, Bhattacharya D, Lim JK, Taddei TH, Justice AC, Lo Re V 3rd. J Hepatol. 2021 Dec; 2021 Jul 29. PMID: 34333102.
- Association of BNT162b2 mRNA and mRNA-1273 Vaccines With COVID-19 Infection and Hospitalization Among Patients With Cirrhosis.John BV, Deng Y, Scheinberg A, Mahmud N, Taddei TH, Kaplan D, Labrada M, Baracco G, Dahman B. JAMA Intern Med. 2021 Oct 1. PMID: 34254978.
- REPLY.John BV, Deng Y, Martin P, Levy C, Taddei TH, Kaplan DE, Dahman B. Hepatology. 2021 Oct; 2021 Aug 15. PMID: 34021933.
- REPLY.John BV, Dahman B, Taddei TH, Levy C, Kaplan DE. Hepatology. 2021 Oct; 2021 Jul 20. PMID: 33942361.
- Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.John BV, Khakoo NS, Schwartz KB, Aitchenson G, Levy C, Dahman B, Deng Y, Goldberg DS, Martin P, Kaplan DE, Taddei TH. Am J Gastroenterol. 2021 Sep 1. PMID: 33989225.
- The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma.Sellers CM, Uhlig J, Ludwig JM, Pollak JS, Taddei TH, Stein SM, Lim JK, Kim HS. Cancer Med. 2021 Aug; 2021 Jul 28. PMID: 34318618.
- Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Noncompletion in the Veterans Health Administration Cohort During the Coronavirus Disease 2019 Pandemic.Mahmud N, Kaplan DE, Goldberg DS, Taddei TH, Serper M. Gastroenterology. 2021 May; 2021 Jan 9. PMID: 33434604.
- Frailty Is a Risk Factor for Postoperative Mortality in Patients With Cirrhosis Undergoing Diverse Major Surgeries.Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Liver Transpl. 2021 May; 2021 Feb 15. PMID: 33226691.
- The Predictive Role of Model for End-Stage Liver Disease-Lactate and Lactate Clearance for In-Hospital Mortality Among a National Cirrhosis Cohort.Mahmud N, Asrani SK, Kaplan DE, Ogola GO, Taddei TH, Kamath PS, Serper M. Liver Transpl. 2021 Feb; 2020 Dec 9. PMID: 33025731.
- Patient Frailty Is Independently Associated With the Risk of Hospitalization for Acute-on-Chronic Liver Failure.Shah S, Goldberg DS, Kaplan DE, Sundaram V, Taddei TH, Mahmud N. Liver Transpl. 2021 Jan; 2020 Oct 28. PMID: 32946660.
- Risk Prediction Models for Post-Operative Mortality in Patients With Cirrhosis.Mahmud N, Fricker Z, Hubbard RA, Ioannou GN, Lewis JD, Taddei TH, Rothstein KD, Serper M, Goldberg DS, Kaplan DE. Hepatology. 2021 Jan; 2020 Dec 10. PMID: 32939786.
- Mortality and Hepatic Decompensation in Patients With Cirrhosis and Atrial Fibrillation Treated With Anticoagulation.Serper M, Weinberg EM, Cohen JB, Reese PP, Taddei TH, Kaplan DE. Hepatology. 2021 Jan; 2020 Nov 9. PMID: 32267547.
- Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline.Gordan JD, Kennedy EB, Abou-Alfa GK, Beg MS, Brower ST, Gade TP, Goff L, Gupta S, Guy J, Harris WP, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Knox JJ, Kortmansky J, Leaf A, Remak WM, Shroff RT, Sohal DPS, Taddei TH, Venepalli NK, Wilson A, Zhu AX, Rose MG. J Clin Oncol. 2020 Dec 20; 2020 Nov 16. PMID: 33197225.
- Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Bräu N, Brown ST, Taddei TH, Justice AC, Lo Re V 3rd. J Acquir Immune Defic Syndr. 2020 Dec 15. PMID: 33185999.
- Assessing the Impact of Referral on Multidisciplinary Tumor Board Outcomes in Patients With Hepatocellular Carcinoma.Zhang Y, Weinreb JC, Czeyda-Pommersheim F, Taddei TH. J Am Coll Radiol. 2020 Dec; 2020 Jun 10. PMID: 32533924.
- Correction to: Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.Do A, Esserman DA, Krishnan S, Lim JK, Taddei TH, Hauser RG 3rd, Tate JP, Re VL 3rd, Justice AC. J Gen Intern Med. 2020 Oct. PMID: 33021712.
- Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.Rentsch CT, Kidwai-Khan F, Tate JP, Park LS, King JT Jr, Skanderson M, Hauser RG, Schultze A, Jarvis CI, Holodniy M, Lo Re V 3rd, Akgün KM, Crothers K, Taddei TH, Freiberg MS, Justice AC. PLoS Med. 2020 Sep; 2020 Sep 22. PMID: 32960880.
- Models for acute on chronic liver failure development and mortality in a veterans affairs cohort.Xiao KY, Hubbard RA, Kaplan DE, Taddei TH, Goldberg DS, Mahmud N. Hepatol Int. 2020 Jul; 2020 Jun 9. PMID: 32519219.
- Excess Weight Gain After Cure of Hepatitis C Infection with Direct-Acting Antivirals.Do A, Esserman DA, Krishnan S, Lim JK, Taddei TH, Hauser RG 3rd, Tate JP, Re VL 3rd, Justice AC. J Gen Intern Med. 2020 Jul; 2020 Apr 27. PMID: 32342483.
- HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Gibert CL, Bräu N, Brown ST, Roy JA, Taddei TH, Justice AC, Lo Re V. J Natl Cancer Inst. 2020 Jul 1. PMID: 31687755.
- Grade 1 Acute on Chronic Liver Failure Is a Predictor for Subsequent Grade 3 Failure.Mahmud N, Sundaram V, Kaplan DE, Taddei TH, Goldberg DS. Hepatology. 2020 Jul; 2020 Apr 3. PMID: 31677284.
- Covid-19 by Race and Ethnicity: A National Cohort Study of 6 Million United States Veterans.Rentsch CT, Kidwai-Khan F, Tate JP, Park LS, King JT Jr, Skanderson M, Hauser RG, Schultze A, Jarvis CI, Holodniy M, Re VL 3rd, Akgün KM, Crothers K, Taddei TH, Freiberg MS, Justice AC. medRxiv. 2020 May 18; 2020 May 18. PMID: 32511524.
- Risk prediction scores for acute on chronic liver failure development and mortality.Mahmud N, Hubbard RA, Kaplan DE, Taddei TH, Goldberg DS. Liver Int. 2020 May; 2019 Dec 26. PMID: 31840390.
- Covid-19 Testing, Hospital Admission, and Intensive Care Among 2,026,227 United States Veterans Aged 54-75 Years.Rentsch CT, Kidwai-Khan F, Tate JP, Park LS, King JT Jr, Skanderson M, Hauser RG, Schultze A, Jarvis CI, Holodniy M, Re VL 3rd, Akgün KM, Crothers K, Taddei TH, Freiberg MS, Justice AC. medRxiv. 2020 Apr 14; 2020 Apr 14. PMID: 32511595.
- Analysis of weekend effect in severe acute liver injury: A nationwide database study.Do A, Ilagan-Ying YC, Taddei TH. Health Sci Rep. 2020 Mar; 2019 Nov 22. PMID: 32166187.
- Differences in Pathology, Staging, and Treatment between HIV(+) and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma.Torgersen J, Taddei TH, Park LS, Carbonari DM, Kallan MJ, Mitchell Richards K, Zhang X, Jhala D, Bräu N, Homer R, D'Addeo K, Mehta R, Skanderson M, Kidwai-Khan F, Justice AC, Lo Re V 3rd. Cancer Epidemiol Biomarkers Prev. 2020 Jan; 2019 Oct 1. PMID: 31575557.
- Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma.Kanneganti M, Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Transplantation. 2020 Jan. PMID: 31283688.
- Reply.Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Hepatology. 2019 Dec. PMID: 31243784.
- Quality Measures, All-Cause Mortality, and Health Care Use in a National Cohort of Veterans With Cirrhosis.Serper M, Kaplan DE, Shults J, Reese PP, Beste LA, Taddei TH, Werner RM. Hepatology. 2019 Dec; 2019 Jun 26. PMID: 31107967.
- Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores.Ioannou GN, Beste LA, Green PK, Singal AG, Tapper EB, Waljee AK, Sterling RK, Feld JJ, Kaplan DE, Taddei TH, Berry K. Gastroenterology. 2019 Nov; 2019 Jul 26. PMID: 31356807.
- Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.Mahmud N, John B, Taddei TH, Goldberg DS. Clin Transplant. 2019 Jul; 2019 Jun 25. PMID: 31177570.
- Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B.Fox RK, Taddei TH, Kaplan DE. JAMA Intern Med. 2019 May 1. PMID: 30882884.
- Incidence and Mortality of Acute-on-Chronic Liver Failure Using Two Definitions in Patients with Compensated Cirrhosis.Mahmud N, Kaplan DE, Taddei TH, Goldberg DS. Hepatology. 2019 May; 2019 Mar 20. PMID: 30615211.
- Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies.Saffo S, Taddei TH. Dig Dis Sci. 2019 Apr. PMID: 30887150.
- Hepatocellular Carcinoma Outcome Is Predicted by Expression of Neuronal Calcium Sensor 1.Schuette D, Moore LM, Robert ME, Taddei TH, Ehrlich BE. Cancer Epidemiol Biomarkers Prev. 2018 Sep; 2018 May 22. PMID: 29789326.
- Palliative care in decompensated cirrhosis: A review.Langberg KM, Kapo JM, Taddei TH. Liver Int. 2018 May; 2018 Jan 15. PMID: 29112338.
- Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching.Kaplan DE, Mehta R, D'Addeo K, Gade TP, Taddei TH. J Vasc Interv Radiol. 2018 Apr; 2018 Feb 22. PMID: 29477619.
- Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort study.Kaplan DE, Mehta R, D'Addeo K, Valderrama A, Taddei TH. Medicine (Baltimore). 2018 Jan. PMID: 29369224.
- Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study.Reiss KA, Yu S, Mamtani R, Mehta R, D'Addeo K, Wileyto EP, Taddei TH, Kaplan DE. J Clin Oncol. 2017 Nov 1; 2017 Sep 5. PMID: 28872925.
- Pursuing a Gastroenterology Fellowship as a Foreign Medical Graduate.Njei B, Taddei TH. Dig Dis Sci. 2017 Aug. PMID: 28555326.
- Comparing Child-Pugh, MELD, and FIB-4 to Predict Clinical Outcomes in Hepatitis C Virus-Infected Persons: Results From ERCHIVES.Butt AA, Ren Y, Lo Re V 3rd, Taddei TH, Kaplan DE. Clin Infect Dis. 2017 Jul 1. PMID: 28369305.
Jittima Weerachayaphorn, PhD
- Neutrophils interact with cholangiocytes to cause cholestatic changes in alcoholic hepatitis.Takeuchi M, Vidigal PT, Guerra MT, Hundt MA, Robert ME, Olave-Martinez M, Aoki S, Khamphaya T, Kersten R, Kruglov E, de la Rosa Rodriguez R, Banales JM, Nathanson MH, Weerachayaphorn J. Gut. 2021 Feb; 2020 Nov 19. PMID: 33214166.
- Type 3 Inositol 1,4,5-Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma.Ueasilamongkol P, Khamphaya T, Guerra MT, Rodrigues MA, Gomes DA, Kong Y, Wei W, Jain D, Trampert DC, Ananthanarayanan M, Banales JM, Roberts LR, Farshidfar F, Nathanson MH, Weerachayaphorn J. Hepatology. 2020 Feb; 2019 Aug 19. PMID: 31251815.
- Effects of Endotoxin on Type 3 Inositol 1,4,5-Trisphosphate Receptor in Human Cholangiocytes.Franca A, Carlos Melo Lima Filho A, Guerra MT, Weerachayaphorn J, Loiola Dos Santos M, Njei B, Robert M, Xavier Lima C, Vieira Teixeira Vidigal P, Banales JM, Ananthanarayanam M, Leite MF, Nathanson MH. Hepatology. 2019 Feb; 2018 Dec 31. PMID: 30141207.
- Dysregulated microRNA expression profiles in cholangiocarcinoma cell-derived exosomes.Kitdumrongthum S, Metheetrairut C, Charoensawan V, Ounjai P, Janpipatkul K, Panvongsa W, Weerachayaphorn J, Piyachaturawat P, Chairoungdua A. Life Sci. 2018 Oct 1; 2018 Aug 27. PMID: 30165035.
- Nonalcoholic fatty liver disease impairs expression of the type II inositol 1,4,5-trisphosphate receptor.Khamphaya T, Chukijrungroat N, Saengsirisuwan V, Mitchell-Richards KA, Robert ME, Mennone A, Ananthanarayanan M, Nathanson MH, Weerachayaphorn J. Hepatology. 2018 Feb; 2018 Jan 2. PMID: 29023819.
- Type 2 inositol trisphosphate receptor gene expression in hepatocytes is regulated by cyclic AMP.Kruglov E, Ananthanarayanan M, Sousa P, Weerachayaphorn J, Guerra MT, Nathanson MH. Biochem Biophys Res Commun. 2017 May 6; 2017 Mar 19. PMID: 28327356.
- Effects of andrographolide on intrahepatic cholestasis induced by alpha-naphthylisothiocyanate in rats.Khamphaya T, Chansela P, Piyachaturawat P, Suksamrarn A, Nathanson MH, Weerachayaphorn J. Eur J Pharmacol. 2016 Oct 15; 2016 Jul 27. PMID: 27475677.
- Nuclear Factor, Erythroid 2-Like 2 Regulates Expression of Type 3 Inositol 1,4,5-Trisphosphate Receptor and Calcium Signaling in Cholangiocytes.Weerachayaphorn J, Amaya MJ, Spirli C, Chansela P, Mitchell-Richards KA, Ananthanarayanan M, Nathanson MH. Gastroenterology. 2015 Jul; 2015 Mar 18. PMID: 25796361.
- Deleterious effect of oltipraz on extrahepatic cholestasis in bile duct-ligated mice.Weerachayaphorn J, Luo Y, Mennone A, Soroka CJ, Harry K, Boyer JL. J Hepatol. 2014 Jan; 2013 Aug 23. PMID: 23978715.
- Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine.Weerachayaphorn J, Mennone A, Soroka CJ, Harry K, Hagey LR, Kensler TW, Boyer JL. Am J Physiol Gastrointest Liver Physiol. 2012 May 1; 2012 Feb 16. PMID: 22345550.
- Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression.Xu S, Weerachayaphorn J, Cai SY, Soroka CJ, Boyer JL. Am J Physiol Gastrointest Liver Physiol. 2010 Jul; 2010 Apr 15. PMID: 20395535.
- Nuclear factor erythroid 2-related factor 2 is a positive regulator of human bile salt export pump expression.Weerachayaphorn J, Cai SY, Soroka CJ, Boyer JL. Hepatology. 2009 Nov. PMID: 19821532.
Xinshou Ouyang, PhD
- Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases.Fujimoto M, Tsutsui H, Xinshou O, Tokumoto M, Watanabe D, Shima Y, Yoshimoto T, Hirakata H, Kawase I, Nakanishi K, Kishimoto T, Naka T. Int Immunol. 2004 Feb. PMID: 14734616.